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Thesis Introduction 
This thesis is comprised of three chapters which encapsulate my research experiences over 
two different clinical placements. Despite the inclusion of opposing content, I believe that 
only by synthesising my work into one complete document have I been able to fully reflect 
upon what I have gained from undertaking the MRes in Clinical Psychology.  
Chapter One: An NHS Ethics Application 
The primary focus of my autumn research placement was to organise, draft and submit an 
NHS ethics application. Our project proposed to investigate the validity of the 
Neuropsychological Assessment Battery Screening Tool (S-NAB) in both patients with 
traumatic brain injury (TBI) and in orthopaedic controls. In order to gain ethical approval for 
the research project from the NHS, I was required to complete an online application using 
the Integrated Research Application System (IRAS).  
In order to do this, I firstly researched the subject field at great length to produce a mini 
literature review and rationale for our research study. I then presented this information at a 
research team meeting, which was used in conjunction with the expertise of others, to 
inform a number of decisions prior to finalising the research design and completing the 
online form to the level of detail required. After submitting the application, myself and two 
members of the research team were required to attend a National Research Ethics Service 
(NRES) committee meeting to discuss our research proposal with a panel of experts. 
Following this, and after making appropriate amendments, we obtained a favourable 
opinion to proceed with the research. 
Thus, Chapter One of this thesis describes four of the core decisions that were made by the 
research team prior to submission for ethical approval.  
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Chapter Two: Qualitative Data Analysis 
For my second research placement I conducted Interpretative Phenomenological Analysis 
(IPA) on the transcripts from semi-structured interviews with six young girls diagnosed with 
either Central Precocious Puberty (CPP) or Premature Adrenarche (PA). As I used IPA in my 
Undergraduate dissertation, I was eager to improve upon the basic skills that I had 
developed previously.  
I obtained the dataset fully transcribed and briefly met with the researcher who had 
conducted the interviews in order to gain background information on the sample. At this 
stage of the placement, I was keen to work independently in order to challenge my own 
research skillset. Thus, I completed the systematic process of coding and theme-building 
and attempted to generate a coherent portrayal of the data. Following peer supervision and 
discussion of themes, I was able to produce an analysis which I believe accurately depicts 
the experiences of these young girls with CPP/PA.  
Chapter Three: An Empirical Research Study 
The third and final chapter of this thesis contains a quantitative research study detailing an 
initial investigation into the construct validity of the S-NAB in persons with TBI. After 
obtaining approval from the Research and Development trust at University Hospitals 
Birmingham (UHB), I was able to collect some of the data included in the analysis. 
The analysis revealed significant associations between the S-NAB and the comparative 
battery of neuropsychological tests, which provides initial support for the construct validity 
of the S-NAB in persons with TBI. As the data collected for this thesis was collected for 
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preliminary investigation alone, the results obtained will be used to guide a larger study 
which is planned to take place over the next few years.  
Reflection 
Instead of discussing each of my clinical research placements separately, I have chosen to 
reflect upon my experiences of the MRes in Clinical Psychology as a whole. Upon 
commencement of the course, I set myself a number of goals which I hoped to achieve over 
the 12-month research degree: 
 I wished to improve upon my skills in both qualitative and quantitative research, and 
apply these within more than one clinical population. 
 I aimed to improve upon a number of key transferable skills that would enhance my 
credentials as an aspiring professional within the field of Clinical Psychology. 
 I hoped to undertake a research placement within an NHS setting in order to gain 
first-hand experience of working within a clinical service and conducting research 
within the NHS.   
In terms of my set goals, I was fortunate enough to complete two very different clinical 
placements that allowed me to produce both quantitative and qualitative research in two 
extremely diverse clinical populations. Prior to this course, I had no experience with either 
TBI or CPP/PA and so I feel very fortunate to have widened my knowledge of two further 
clinical populations.  
For both research placements I was required to utilise very different transferable skills. On 
placement two, I worked independently by managing my own workload and setting myself 
personal targets. In particular, I had to ensure that I carefully stuck to deadlines by 
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managing my time effectively, which is extremely challenging when conducting thorough 
qualitative analysis. In addition to this, I developed self-awareness, improved my attention 
to detail and took responsibility for the quality of my own work. 
On the other hand, as a research assistant on the S-NAB project I was expected to 
contribute as part of a highly specialised clinical research team. I was required to complete 
numerous set tasks and communicate effectively with team members over multiple NHS 
sites. Thus, as a result of such differing experiences, I believe I have had the opportunity to 
develop a multitude of transferable skills that I will take forward and utilise extensively.  
In regards to personal development, I feel as though I played an active and integral role in 
the decision-making process on the S-NAB project. Despite all other members of the 
research team specialising in TBI, I felt as though my contribution was valued and influential 
over the decisions made regarding the research project. This experience provided me with 
the confidence to enter into my summer-term placement with enthusiasm and a good 
understanding of the assessment procedure involved in testing. 
Finally, as part of the S-NAB research project I was given the opportunity to contribute 
towards data collection by completing testing sessions with individuals who had sustained a 
TBI. Thus, I obtained an honorary contract as an Assistant Psychologist within the 
Neuropsychology department at UHB. Not only did this enhance my clinical skills and 
provide me with the opportunity to conduct neuropsychological assessments, as a result of 
this experience I gained a first-hand insight into the day-to-day functioning of the NHS.  
After now completing my thesis, I believe that all of my initial targets were achieved 
throughout my clinical placements. Moreover, I feel as though this research degree has 
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provided me with a platform on which I have developed both personally and professionally. 
As a research assistant, I have been given the opportunity to work independently and build 
confidence in my own abilities. Thus, I am extremely proud of the content included in this 
research thesis, which has been produced as a result of my own hard work and dedication.  
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Introduction 
Traumatic brain injury (TBI) is one of the most cited causes of acquired cognitive deficiency 
in individuals of all ages (Thurman, Coronado & Selassie, 2007). Impairment is variable; 
injuries occur on a continuum of severity ranging from minor complaints requiring minimal 
medical attention, to critical incidents that result in permanent disability or even death 
(Iverson, Holdnack, & Lange, 2013). The administration of neuropsychological tests is an 
essential component involved in post-injury assessment (Iverson, Brooks & Holdnack, 2008). 
Literature indicates that accurate identification of cognitive impairment following a TBI is 
predictive of an individual’s future prognosis; results are used to guide the recommendation 
of interventions to alleviate injury and the amount of future support required by individuals 
(Powell, Ferraro, Dikmen, Temkin & Bell, 2008). Ideally, patients undergo a thorough 
neuropsychological assessment that provides a comprehensive evaluation of the five 
principle cognitive domains (language, memory, executive functioning [EF], attention and 
spatial reasoning) following head trauma (Hofgren, 2009). However, this assessment 
procedure requires extensive administration time, which often results in patient frustration 
due to lower tolerance levels and heightened fatigue in people who are in acute and post-
acute settings (Zgaljardic & Temple, 2010). Allen, Thaler, Cross and Mayfield (2013) suggest 
that a brief cognitive screening tool would be a more effective method of assessment during 
this time. A well validated and reliable screening tool would serve as a means of highlighting 
immediate cognitive strengths and limitations following a TBI, which can then be 
investigated in more depth during the initial stages of rehabilitation (Zgaljardic & Temple, 
2010). 
11 
 
The research team were required to make a number of imperative choices regarding the 
design of the project prior to the application for NHS ethical approval. In this chapter, four 
of the most fundamental decisions are discussed in terms of scientific and practical 
reasoning:  
(1) What is the rationale for selecting the Neuropsychological Assessment Battery 
Screening Tool (S-NAB) as a potential screening assessment for persons with a TBI? 
(2) What is the rationale for selecting the Neuropsychological assessments included in 
the comparative test battery? 
(3) What is the rationale for the inclusion of performance validity tests? 
(4) What is the rationale for the inclusion of orthopaedic controls? 
What is the Rationale for Selecting the Neuropsychological Assessment Battery Screening 
Tool (S-NAB) as a Potential Screening Assessment for Persons with a TBI? 
Before selecting which cognitive screening instrument to investigate, a literature review was 
produced in order to ascertain the tests that are routinely used to identify cognitive 
impairment in patients with a TBI.  
Due to the heterogeneity in cognitive impairment following a serious head injury, 
comprehensive neuropsychological evaluation is conducted to attain detailed information 
that can be used by clinicians to inform treatment planning (Allen et al., 2013). As a result of 
the diversity associated with acquired neuropsychological impairment, a substantial number 
of cognitive screening tests have been developed in order to assess various clinical 
populations (as discussed in the review by Cullen, O’Neill, Evans, Coen & Lawlor, 2007). 
Despite the large number of neuropsychological screening tools in existence, no single 
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instrument has received adequate agreement across professionals to warrant worldwide 
administration (Brodaty et al., 1998; Cullen et al., 2007). Further to this, few assessments 
have been validated within specific clinical populations such as TBI (McKay, Casey, 
Wertheimer & Fichtenberg, 2007).  
In their review of neuropsychological batteries, Pawlowski, Segabinazi, Wagner and 
Bandeira (2013) identified five key screening instruments which are currently administered 
to patients who have suffered a TBI:  
(a) The Mini Mental State Examination (MMSE; Folstein, Folstein & McHugh, 1975), 
(b) The Addenbrooke’s Cognitive Examination- Revised (ACE-R; Mioshi, Dawson, 
Mitchell, Arnold & Hodges, 2006), 
(c) The Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005), 
(d) The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS; 
Randolph, Tierney, Mohr & Chase, 1998), 
(e) The Neuropsychological Assessment Battery Screening Tool (S-NAB; Stern & White, 
2003) 
In general, neuropsychological instruments should meet particular requirements before 
being considered for use within clinical care (Hofgren, 2009). A number of key prerequisites 
were identified following a review of the literature available. As previously stated, research 
has placed great emphasis on the need for brief Neuropsychological evaluation in the 
immediate aftermath of a TBI occurring (Zgaljardic & Temple, 2010). Further to this, and as a 
result of the lengthy rehabilitation required post-injury, parallel versions of a screening tool 
allow for clinicians to monitor the progression of an individuals’ cognitive functioning over 
time (Allen et al., 2013). Ultimately, a comprehensive Neuropsychological assessment 
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should provide results on the functioning of all five core cognitive domains (Temple et al., 
2009). In addition to this, an adequate screening tool should demonstrate sensitivity and 
specificity to cognitive impairment, which ensures that Type 1 and Type 2 errors are 
minimised (Pawlowski et al., 2013). The existing literature outlines that minimum acceptable 
levels of sensitivity and specificity should be above 0.60 for clinical utility (McKay, 
Wetheimer, Fichtenberg & Casey, 2008). In order to achieve this, Neuropsychological tests 
should have extensive normative data that accounts for age, gender and educational 
attainment, which allows for more accurate identification of impairment across all 
demographic backgrounds (Temple et al., 2009). Finally, it is imperative that cognitive 
screening tools are validated within the particular clinical populations for which they intend 
to be implemented (Donders & Levitt, 2012); verification is typically achieved through 
adequate research support. The following quality criterion was therefore developed in order 
to examine the suitability of using each of the five cognitive screening tests to assess 
patients with a TBI: 
Table 1:  
Quality criterion for screening tests 
1. Can the screening instrument be administered in less than 1 hour?                    Yes/No 
2. Are there parallel versions of the screening tool available to allow                      Yes/No 
 for repeat testing?  
3. Does the screening instrument cover all 5 cognitive domains?                             Yes/No 
4. Is there adequate research to demonstrate specificity and                                    Yes/No 
sensitivity for cognitive impairment? 
5. Does the screening instrument have normative data that accounts                     Yes/No 
 for gender, age and previous education? 
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6. Is the screening instrument considered suitable for people with                          Yes/No 
a TBI? 
 
The screening tools listed above were assessed against these criteria.  
The Mini Mental State Examination (MMSE) 
The MMSE is considered the most widespread screening tool used to briefly assess cognitive 
deficiency in people with varying conditions worldwide (Cullen et al., 2007). Although 
predominantly used to identify dementia, the MMSE is cited within the literature as a 
candidate screening tool for TBI (Damian et al., 2011). The MMSE can be administered in 
approximately 10 minutes, giving a score that is “useful in quantitatively estimating the 
severity of cognitive impairment” (Tombaugh & McIntyre, 1992). Additionally, as a result of 
its extensive use, the test boasts a respectable amount of normative data that controls for 
differences in both age and previous education attainment (Crum, Anthony, Bassett & 
Folstein, 1993). However, the absence of parallel versions limits the opportunity for repeat 
testing. Further to this, despite an overwhelming presence throughout the literature, some 
research suggests that the MMSE is now outdated and largely insensitive to screening for 
cognitive impairment (Carone, Burns, Gold & Mittenberg, 2004; Gaber, 2008), especially 
when differentiating between adequately functioning individuals and those presenting with 
mild cognitive deficit (Pendlebury, Cuthbertson, Welch, Mehta & Rothwell, 2010). 
Fundamentally, the MMSE is unable to assess all five core cognitive domains, as its highly 
verbal content results in an absence of visuoperceptual and visuoconstructional data 
(Hofgren, 2009). In addition to this, the specificity and sensitivity of the MMSE has been 
continually questioned within the literature (Damian et al., 2011; Gaber, 2008; Naugle & 
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Kawczak, 1989). Originally, Nelson, Fogel and Faust (1986) observed very high false negative 
scores when using the MMSE.  Most recently, Galioto and colleagues (2013) reported low 
sensitivity and specificity in detecting cognitive impairment, despite applying the most 
stringent cut-off values during data analysis. The inability to differentiate between 
individuals with and without dysfunction ultimately results in an inaccurate functional 
outcome prediction (Feher et al., 1992), and, in some cases, failure to detect gross cognitive 
impairment altogether (Gaber, 2008; Srikanth, Quinn, Donnan, Saling & Thrift, 2006). Finally, 
a number of studies have rejected the notion of the MMSE as a suitable cognitive screen 
following a TBI due to the discrepancies previously discussed (Gaber, 2008; Nys et al., 2005; 
Srivastava et al., 2006). In sum, Larner (2013) postulated that despite the inaccuracy and 
ineffectiveness of the MMSE, it provides a useful “benchmark” to compare against 
alternative cognitive screening tools.  
Addenbrooke’s Cognitive Examination (ACE-R) 
The ACE-R was developed as a response to the criticisms of the MMSE (Gaber, 2008). It 
takes approximately 20 minutes to administer and was specifically designed to identify 
individuals with dementia (Mathuranath, Nestor, Berrios, Rakowicz & Hodges, 2000).  The 
ACE-R is comprised of the MMSE, as well as further assessment material with a focus on 
memory and spatial functioning (Pendlebury, Mariz, Bull, Mehta & Rothwell, 2012). There 
are no parallel versions to allow for repeat testing. The ACE-R has demonstrated good 
sensitivity and specificity when administered on people with dementia (Larner, 2007; Larner 
& Mitchell, 2014), however, only one study to date has utilised the ACE-R on a sample of 
individuals with a TBI (Gaber, 2008). Their results evidenced that the ACE-R scored 72% 
sensitivity to cognitive impairment, in comparison to 36%, which was reported following the 
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administration of the MMSE on the same sample. However, despite reporting good 
sensitivity and specificity in their TBI study, Gaber (2008) proposed that clinical utility of the 
ACE-R is restricted by the distinct lack of normative data available. Existing normative data is 
limited to either healthy middle-aged and elderly performance or values for individuals 
diagnosed with dementia from the ages of 46 to 86 (Amaral-Carvalho & Caramelli, 2012). 
Thus, there is an absence of normative data in younger age groups (as detailed in Mioshi et 
al., 2006). With regards to administration of the ACE-R on individuals with a TBI, only 
Gaber’s (2008) study is in existence. Until further research is conducted, the ACE-R cannot 
be considered as a suitable cognitive screening tool following a TBI.   
The Montreal Cognitive Assessment (MoCA) 
Fundamentally, designed as a short screen for global cognitive functioning, the MoCA was 
originally intended to identify mild cognitive deficit (Nasreddine et al., 2005). The test can 
be administered in approximately 10 minutes but does not possess parallel versions for 
repeat testing. Similar to the ACE-R, the MoCA assesses attention, memory, language, 
spatial and EF (Nasreddine et al., 2005). Research investigating the clinical utility of the 
MoCA has demonstrated good sensitivity and specificity in persons with dementia (Freitas, 
Simões, Marôco, Alves & Santana, 2012), Parkinson’s disease (Nazem et al., 2009) and with 
individuals post-stroke (Cumming, Bernhardt & Linden, 2011). However, discrepancies can 
be found within the literature, as demonstrated by Godefroy and colleagues (2011) who 
reported that the high sensitivity of the MoCA was at the expense of low specificity. A 
further limitation of the MoCA surrounds the substantial absence of normative data 
available. Most recently, Julayanont, Phillips, Chertkow and Nasreddine (2013) suggested 
that further accumulation of normative data is required before the MoCA can be routinely 
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used within routine clinical practice. In addition to this, there is a limited amount of research 
available demonstrating the application of the MoCA on patients with TBI. Of the studies in 
existence, Wong and colleagues (2013) reported that the MoCA is “a useful and 
psychometrically valid tool for the assessment of gross cognitive functioning” in persons 
with a TBI. Conversely, de Guise and colleagues (2013) concluded that the MoCA was no 
better at identifying cognitively impaired individuals with a TBI than the MMSE; both tests 
demonstrated poor sensitivity to impairment following head trauma. Thus, further research 
is required to expand upon both normative and TBI data in regards to clinical utility of the 
MoCA.  
The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) 
The review by Pawlowski and colleagues (2013) identified the RBANS as the most widely 
used cognitive screening instrument used to measure impairment in patients with TBI. 
Overall, the literature indicates that the RBANS is a reliable tool that provides a global 
impairment total, along with 5 individual index scores that are generated from the scores of 
12 subtests. The five neurocognitive index scores explore Immediate Memory, 
Visuospatial/Constructional functioning, Language, Attention and Delayed Memory 
(Randolph et al., 1998). Administration of the RBANS has become more popular since its 
initial development due to advantages such as being brief in application, the provision of 
extensive normative data and the availability of parallel versions which allow for repeat 
administration (McKay, Casey, Wertheimer & Fichtenberg, 2007). As with the previously 
discussed cognitive screens, the RBANS was initially developed to assess for dementia 
(Randolph, 1998), however, it has since been utilised as a cognitive screening tool in a 
number of clinical populations such as Parkinson’s disease (Yang, Garrett-Mayer, Schneider, 
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Gollomp & Tilley, 2009), Multiple Sclerosis (Beatty, 2004) and Huntington’s disease 
(Randolph et al., 1998). The overall RBANS impairment total has been explored in depth, 
demonstrating good sensitivity and specificity (as summarised in McKay et al., 2008), 
however, validation of the individual index scores is lacking. McKay and colleagues (2007) 
highlighted this paucity in the literature and examined construct validity by correlating each 
of the five RBANS index scores with a battery of well-established neuropsychological tests. 
Two cognitive domains (Immediate and delayed memory, visuospatial/constructional) 
revealed moderate to strong correlations, however, the attention and language index scores 
demonstrated weak construct validity. This mirrors the findings of Larson, Kirschner, Bode, 
Heinemann and Goodman (2005). The RBANS has been used extensively to detect 
impairment following Acquired Brain Injury (Pachet, 2007) and TBI (Carone et al., 2004). 
Despite this, the RBANS fails to adequately assess EF, which is a core neurocognitive domain 
that is frequently disrupted in individuals with a TBI (Bivona et al., 2008). In addition to this, 
Zgaljardic and Temple (2010) hold the view that the RBANS is not specialised enough to 
accurately discriminate between the diverse neuropsychological presentations often 
observed following head trauma. Thus, despite the large number of advantages associated 
with the RBANS, an alternative screening tool which has been developed for specialised use 
within a TBI setting could prove more clinically useful (Zgaljardic & Temple, 2010).  
The Neuropsychological Assessment Battery Screening Tool (S-NAB) 
The NAB Screening module is one of the six components that make up the full 
Neuropsychological Assessment Battery. The S-NAB takes approximately 45 minutes to 
administer and has two parallel versions to allow for repeat testing (Stern & White, 2003). In 
addition to this, the S-NAB boasts substantial demographically corrected normative data 
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that accounts for age, gender and previous educational attainment (White & Stern, 2003). 
The S-NAB is structurally similar to the RBANS, as it provides an examination of overall 
cognitive functioning as well as five individual cognitive index scores: Attention, Language, 
Executive Functions, Memory and Visuospatial functioning. Most of the existing empirical 
research on the S-NAB has focused on patients with TBI, however, only six studies are 
available to date (Cannizzaro, Elliott, Stohl, Hasin & Aharonovich, 2014; Grohman & Fals-
Stewart, 2004; Iverson, Williamson, Ropacki & Reilly, 2007; Temple et al., 2009; Zgaljardic & 
Temple, 2010; Zgaljardic, Yancy, Temple, Watford & Miller, 2011). Thus, validation of the S-
NAB has been largely unexplored, specifically in regards to the construct validity of each of 
the individual index scores, and the sensitivity and specificity of the S-NAB in differentiating 
between impairment and adequate functioning. Initial research has demonstrated good 
sensitivity and specificity following the administration of the S-NAB on persons with a TBI 
(Temple et al., 2009). This preliminary research points towards the potential utility of the S-
NAB compared with the other four tests discussed within both inpatient and rehabilitation 
settings following TBI (Zgaljardic & Temple, 2010). Thus, this gap in the literature provides 
an ideal platform on which to base the current research question.  
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Table 2:  
Assessment of five neuropsychological screening tools against the quality criteria 
 
 
 
The MMSE 
 
ACE-R 
The 
MoCA 
 
The RBANS 
 
The S-NAB 
 
1. Can the screening 
instrument be 
administered in less 
than 1 hour? 
 
 
 
 
 
 
 
 
 
 
 
2. Are there parallel 
versions of the 
screening tool 
available to allow for 
repeat testing? 
 
 
 
 
 
 
 
 
 
 
 
3. Does the cognitive 
screening instrument 
assess all five 
cognitive domains? 
 
(Absence of 
Spatial 
examination) 
 
 
 
  (Absence of 
Executive 
Function 
examination) 
 
 
 
4. Is there adequate 
research to 
demonstrate 
specificity and 
sensitivity for 
cognitive 
impairment? 
 
 
 
- In 
Dementia  
- In 
TBI  
 
 
 
 
 
Mixed 
results 
 
 
 
 
 
(Insufficient 
research 
available) 
 
5. Does the screening 
tool have normative 
data that accounts for 
gender, age and 
previous education? 
 
 
 
 
 
 
 
 
 
 
 
6. Is the screening 
instrument 
considered suitable 
for use on persons 
with a TBI? 
 
 
 
 
 
 
 
 
 
 
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What is the Rationale for Selecting the Neuropsychological Assessments Included in the 
Comparative Test Battery? 
In order to test for the construct validity of the S-NAB index domains, a correlation between 
each index total and the scores from a matched “gold standard” neurocognitive test was 
deemed most appropriate. The following well-established neuropsychological assessments 
were selected following a review of the literature:  
The Wechsler Adult Intelligence Scale (WAIS-IV; Wechsler, 2008) and Wechsler Memory 
Scale (WMS-IV; Wechsler, 2009) 
Often paired together in clinical practice, the WAIS-IV and WMS-IV were considered ideal 
neuropsychological tests to validate the memory, language, attention and visuospatial S-
NAB index scores. The WAIS-IV is comprised of four index domains that measure Verbal 
Comprehension, Perceptual Reasoning, Working Memory and Processing Speed (Wechsler, 
2008). Alternatively, Auditory Memory, Visual Memory, Visual Working Memory, Immediate 
Memory and Delayed Memory are the five index scores assessed by the WMS-IV (Wechsler, 
2009). The WAIS-IV and WMS-IV are considered “part of a comprehensive battery for 
assessing cognition” and have been used extensively to detect impairment following TBI 
(McKay et al., 2008). There is a wealth of validation data available which details the 
sensitivity and specificity of the WAIS-IV and WMS-IV (and previously the WAIS-III and WMS-
III) when identifying cognitive impairment following a TBI (Iverson, Holdnack & Lange, 2013). 
In addition to this, both tests boast a comprehensive set of demographically adjusted norms 
that take into account age, gender and education (Iverson, Holdnack & Lange, 2013; 
Wechsler, 2009).  
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The Delis-Kaplan Executive Function System (D-KEFS; Delis, Kaplan & Kramer, 2001) 
The D-KEFS is an extremely well-established measure of EF in both clinical and non-clinical 
populations (as reviewed in Delis, Kramer, Kaplan & Holdnack, 2004). The test 
comprehensively examines the components associated with EF by exploring verbal and 
spatial performance in tasks which demand the demonstration of planning, inhibition and 
problem solving abilities (Delis & Kramer, 2004). The D-KEFS is comprised of a number of 
“established” tasks (e.g., Stroop) as well as more recently designed procedures as one 
comprehensive measure of EF (Delis, Kaplan & Kramer, 2001). It has comprehensive 
normative data and extremely high validity, as supported by a wealth of literature (as 
summarised in Homack, Lee & Riccio, 2005). The D-KEFS has been utilised within numerous 
neuropsychological studies and individuals with TBI are one of the most extensively studied 
clinical populations (Heled, Hoofien, Margalit, Notavich & Agranov, 2012). 
What is the Rationale for the Inclusion of Performance Validity Tests? 
The issue of performance legitimacy during cognitive testing has been researched in depth 
for many years (Larrabee, 2012). Guidelines from the British Psychological Society (BPS) 
support the inclusion of performance validity testing as part of routine clinical assessment of 
cognition in adults (BPS, 2009). Investigating the validity of participants’ assessment 
performance is imperative, as failure to detect invalid test scores may result in inaccurate 
impairment diagnosis (Larrabee, 2012). The term “performance validity” was put forward by 
Larrabee (2012) to replace previously utilised, less accurate terms such as “response bias” or 
“effort”. The possibility that individuals inaccurately report symptoms or underperform on 
psychometric testing for external incentives such as material gain (often compensation or 
disability claims) or avoidance of legal responsibility (such as military duties, criminal 
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sentencing) has been a concern raised worldwide (Binder, 1990). Larrabee, Greiffenstein, 
Greve and Bianchini (2007) opined that a number of factors must be present to warrant the 
use of terminology such as “Malingered Neurocognitive Dysfunction”: the individual must 
(1) have a significant external incentive, (2) consistently demonstrate invalid test 
performance on numerous assessments, and (3) demonstrate performance that would be 
considered atypical of severe impairment.  
In general, performance validity testing is designed to be simple to complete and is 
validated to be insensitive to all but the most profound cognitive impairment (e.g. 
Dementia) (BPS, 2009). Thus, failure of performance validity tests is rare, and cannot be 
explained by potentially confounding factors such as pain, mood, or cognitive functioning 
(Larrabee, 2012). As a result, failure on such tasks is often considered indicative of 
performance invalidity, which therefore signals that the individual’s results should not be 
wholly relied upon (Delis & Wetter, 2007).   
There exists a wealth of literature demonstrating the impact of invalid performance, which 
is considered as more prominent in conditions such as mild TBI (Green, Rohling, Lees-Haley 
& Allen, 2001). Binder (1993) reported that 33% of their participants with a mild TBI who 
were involved in compensation claims had exaggerated cognitive impairments. Further to 
this, in a study by Green (2007), results obtained from conducting the California Verbal 
Learning Test were not able to discriminate between impairment and adequate functioning 
in individuals following a TBI until those who failed a performance validity test were 
removed. A comprehensive evaluation of further studies detailing the impact of 
performance invalidity can be found in a review by Rohling and colleagues (2011).   
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In order to detect inaccurate scoring, a number of performance validity tests have been 
embedded within well-established neuropsychological batteries used to assess cognitive 
impairment (Larrabee, 2012). Two of the most clinically utilised performance validity tests 
are the Word Memory Test (WMT; Green, Allen & Astner, 1996) and the Test of Memory 
Malingering (TOMM; Tombaugh, 1996). Both measures were developed to recognise 
performance invalidity and have been researched in depth (Lally, 2003; Gervais, Rohling, 
Green & Ford, 2004).  For example, Stevens, Friedel, Mehren and Merten (2008) found that 
a pass or failure on the WMT was a better predictor of an individuals’ neuropsychological 
profile rather than severity of injury as recorded at hospital admittance. Both the WMT and 
TOMM appear largely unaffected by age, educational attainment and moderate cognitive 
deficit (Larrabee, 2012). Thus, in order to monitor for performance invalidity, the WMT and 
TOMM were selected as part of the well-established battery of comparative 
neuropsychological measures included in the current study. It was hypothesised that the 
inclusion of two measures of performance validity, administered at different stages of 
testing, would increase sensitivity to detecting invalid performance. Failure to pass the 
WMT or TOMM would lead to exclusion of participant scores from data analysis.   
What is the Rationale for the Inclusion of Orthopaedic Controls? 
The second research objective was to examine the sensitivity and specificity of the S-NAB. In 
order to do this, it was imperative to demonstrate that the S-NAB is able to correctly 
identify cognitive impairment in persons who had suffered a TBI, and thus differentiate 
these individuals from persons who had not previously suffered head trauma. Throughout 
empirical research, the demographic background of both the subject and control group is a 
factor that is highly influential over the results obtained (Landre, Poppe, Davis, Schmaus & 
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Hobbs, 2006). Thus, the inclusion of matched controls is essential to any robust study 
design. In terms of TBI, an adequately matched control group serves as an indicator of the 
performance of non-injured persons, allowing for observation of the impact of head trauma 
(Mathias, Dennington, Bowden & Bigler, 2013). 
Over recent years, it has been recommended to match individuals who had experienced a 
TBI with orthopaedic controls who had suffered injury that was devoid of head trauma 
(Landre et al., 2006; Taylor & Alden, 1997). This is due to similar background profiles of 
orthopaedic controls, along with their experiences of receiving treatment for an injury 
(Mathias et al., 2013). More specifically, research has suggested that individuals who 
experience non-head-related injuries are more likely to have similar demographic (e.g., 
gender, age, socio-economic background, education attainment), and psychosocial (e.g., risk 
taking behaviours observed more often in young males) presentations to those who are 
hospitalised with a TBI (Fischer, Trexler & Gauggel, 2004). In addition to this, due to the time 
spent in hospital, orthopaedic control subjects are also more likely to have had similar 
injury-related experiences (e.g., medication administration, pain management, and stress 
during hospitalisation) to individuals with a previous history of TBI (Satz, et al., 1999). This 
experience discriminates orthopaedic controls from alternatively demographically matched 
members of the community, ensuring that orthopaedic subjects are more suitable for use 
within clinical research on TBI (Mathias et al, 2013). 
Reflection 
See Appendix 1A for Chapter One reflection. 
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CHAPTER TWO: 
A QUALITATIVE EXPLORATION INTO THE EXPERIENCES OF CHILDREN DIAGNOSED WITH 
CENTRAL PRECOCIOUS PUBERTY OR PREMATURE ADRENARCHE 
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For my second placement, I performed a qualitative analysis on six transcripts from 
interviews that had been previously conducted with young girls diagnosed with Central 
Precocious Puberty (CPP) or Premature Adrenarche (PA). 
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The primary objective of my placement was to produce a detailed phenomenological 
account of the experiences of young girls with CPP or PA. To do this, I used Interpretative 
Phenomenological Analysis (IPA) to produce a comprehensive overview of any themes that 
emerged from the interview data. It was planned that my analysis would contribute as part 
of a larger study that aimed to gain insight into the lived experiences of premature sexual 
maturity.  Semi-structured interviews had been conducted with the girls’ mothers as part of 
a previous MRes Clinical Psychology placement. Analysis of these exchanges generated 
three core themes: ‘The drive to appear normal’, ‘Anxieties regarding the future’ and ‘The 
importance of communication’. Thus, attainment of the children’s data would allow for 
experiential comparisons, as well as providing a more comprehensive insight into the direct 
impact of having a diagnosis of PA or CPP.   
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”Puberty” is defined as “The period during which adolescents reach sexual maturity and 
become capable of reproduction” (“Puberty,” Oxford English online dictionary). Puberty is a 
stage of considerable physical, cognitive and social development that results from two 
separate processes: Adrenarche (Primarily the growth of pubic and axillary hair) and 
Gonadarche (The release of oestrogen that leads to breast development and fat 
redistribution) (Dixon & Ahmed, 2007). Typically, Adrenarche and Gonadarche occur in 
parallel, leading to the maturation of secondary sexual characteristics in girls and boys over 
the ages of 8 and 9, respectively. However, a small proportion of young children experience 
pubertal development before these milestones.  
Sexual precocity occurs in 0.2% of females under the age of 8 years-old, whilst fewer than 
<0.05% of males experience characteristics of puberty before the age of 9 (Teilmann, 
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Pedersen, Jensen, Skakkebæk & Juul, 2005). Early pubertal development can take place in 
alternative forms and may consist of a multitude of physical repercussions. Two of the most 
common diagnoses are ‘Premature Adrenarche’ and ‘Central Precocious Puberty’. Children 
diagnosed with CPP experience both Adrenarche and Gonadarche, which includes the 
commencement of menstrual bleeding in girls. Alternatively, a diagnosis of PA is limited to 
Adrenarche alone. Individuals diagnosed with early onset puberty often receive treatment 
in the form of Gonadotropin-releasing hormone agonist therapy, where regular injections 
are administered in an attempt to delay sexual development.  
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Interpretative Phenomenological Analysis is a qualitative approach that encourages the 
researcher to explore a phenomenon through the exploration of individuals’ lived 
experiences. IPA has been used extensively by researchers attempting to gain insight into 
the experiences of a number of distinct clinical populations (Biggerstaff & Thompson, 2008). 
In terms of the current research project, IPA was selected as a useful analysis style for 
thoroughly exploring the experiences of a relatively novel clinical population.  
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Six girls between the ages of 6 and 9 years-old who had been diagnosed with either PA or 
CPP were interviewed by a separate researcher. Prior to each semi-structured interview, 
informed written consent was obtained from parents who were present with their child 
throughout. Due to the sensitive nature of the research topic and the young age of 
participants, the researcher was not permitted to directly question children about their 
diagnosis unless the topic had been raised by participants first. Thus, the researcher used a 
number of indirect techniques in order to provoke conversation relating to their experiences 
of PA/CPP. One way in which this was achieved was through the use of props. For example, 
participants were presented with a selection of ‘worry cards’, which showed images of 
general everyday childhood worries (such as the dentist and monsters) alongside issues that 
may be associated with a diagnosis of early onset puberty (i.e., needles and self-image). A 
number of different child-based props were utilised throughout the interviews to indirectly 
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facilitate conversation that related to the girls’ experiences of having a diagnosis of PA/CPP. 
Interviews were recorded and transcribed verbatim by the alternative researcher.  
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At the beginning of my placement, I obtained all six interviews fully transcribed. Throughout 
the analytical process, I followed the guidelines outlined by Smith, Flowers and Larkin 
(2009). To familiarise myself with the data, I read through each transcript and noted down 
my immediate impressions. This process made up the free coding stage of analysis. I then 
revisited each transcript separately and conducted thorough line-by-line coding, where I 
identified the personal topics of importance for each individual (objects of concern), 
alongside their meaning (experiential claims) and participants’ feelings towards them (their 
stance). For this stage of IPA, I was required to use my personal interpretation of individual 
experiences. After completing the line-by-line coding on multiple transcripts, I began to 
recognise the emergence of a number of tentative themes. Next, I grouped together similar 
topics into groups of subthemes, whilst cautiously attempting to preserve the complexity of 
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the dataset. At this stage, I was able to arrange subthemes under two superordinate themes 
which I believed most suitably encapsulated the overall story of the data.   
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My analysis produced two sets of superordinate themes: The explicit experiences of being 
diagnosed with PA or CPP versus the implicit repercussions of living with the conditions. In 
general, the children explicitly discussed their healthcare experiences as being largely 
passive; the general consensus implied that their medical condition was an inconvenience to 
life that they simply had to “get on with”. Despite this perceived resilience, as a group, the 
girls alluded to aspects of social impairment whilst describing a number of interactions 
within their social world. Although not explicitly stated, the underlying connections between 
their experiences of having PA/CPP and their perceived subsequent social fragility should be 
considered. 
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The first superordinate theme to emerge from the data concerned participants’ explicit 
experiences of being diagnosed with PA or CPP. Following IPA, I thought it was most 
appropriate to separate this into a hierarchy comprising three core subthemes: ‘The 
Inconvenience and Discomfort of Hospital Visits’, ‘Temperamental Repercussions of having 
PA/CPP’ and ‘Maintaining Self-esteem’. Each subtheme integrated numerous related topics 
that were discussed by more than one participant. The diagram above provides a visual 
illustration of how IPA allows for the complexities of qualitative data to be arranged in a way 
that forms a coherent experiential account of a particular phenomenon.  
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The first subtheme encapsulated the girls’ experiences of attending compulsory hospital 
visits. Many participants discussed their aversion to the injections they receive as part of 
their treatment plan. Further to this, some girls expressed anxieties regarding what could 
happen to them during hospital visits. When taking into consideration the age group in 
question, participants’ concerns appear reasonable, as young children would often associate 
a hospital environment with ill-health and pain. 
On the other hand, many of the participants gestured towards their personal bravery during 
hospital visits. Perceived resilience was recognisable throughout, as many of the girls 
suggested that injections were an unavoidable necessity to their lives. In opposition, an 
alternative issue concerning hospital attendance was often shared: boredom. The majority 
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of the girls discussed the continued, reliable inconvenience posed by appointments to which 
they played a largely passive role, as opposed to their parents who were regularly reported 
as leading key discussions with medical professionals.  
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One frequently discussed repercussion of precocious development was the continued 
efforts to control hormonal outbursts. The girls provided an insight into the unpredictability 
of their emotions and the social consequences of mood swings. In addition to this, a number 
of individuals discussed the practical strategies they implemented to reduce the negative 
impact of their outbursts, which included largely independent tasks such as reading or 
watching TV. 
In spite of the physical characteristics of their diagnoses, when asked, many of the girls 
reported feeling no different to their peers. However, some participants described 
situations that were unavoidably influenced by their condition, which included participation 
in sport, changing in front of others and requiring flexible access to toilets during their 
menstrual cycle.  
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Despite the explicitly negative consequences of PA and CPP, a number of the girls put 
forward positive aspects of their condition. Whilst some reported taking pleasure from 
experiencing aspects of “growing up” before their peers, others were comforted by the 
knowledge that particular aspects of puberty would be “out of the way” (e.g. managing 
spots). 
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 The final explicit subtheme concerned participants’ self-esteem. Despite the physical and 
emotional consequences of PA/CPP, none of the girls indicated that their condition severely 
impacted on their lives. The data showed an overall indifference, where phrases such as 
“take no notice of it”, “just get on with it” were regularly used to describe participants’ 
diagnosis.  
In addition to their indifference, when asked about general concerns, almost all of the girls 
raised issues that were unrelated to their conditions. Aside from two girls who reported 
anxieties regarding injections, many gave the impression that everyday worries (such as the 
dentist and pressures of school life) were at the forefront of their daily lives.  
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Finally, the subject of ‘appearing different’ was discussed at length during interviews. All 
participants were questioned about their appearance, to which many confirmed feeling 
different to their peers. However, when asked about exact physical dissimilarities, 
individuals focused on characteristics such as ethnicity, religion and hair colour, as opposed 
to explicit characteristics of PA/CPP.  
When considering the aforementioned explicit factors of the PA/CPP diagnosis, it is difficult 
to identify aspects of participants’ self-confidence that is profoundly impacted upon by their 
condition.  
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The second superordinate theme concerned the implicit repercussions of having PA or CPP, 
as inferred by the dataset. Following my analysis, I chose against separating each subject 
topic into separate subthemes, opting instead to group all five of the emerging themes 
under the broader concept of ‘Social Distance’. As before, all topics were discussed by 
multiple participants. 
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Some of the participants chose to discuss their condition with friends and teachers; others 
preferred to maintain their privacy. These children disclosed numerous situations where 
they deceived others in order to conceal their diagnosis.  
Many participants divulged information regarding ongoing conflicts with their peers. Whilst 
mild conflict is an everyday part of school-life, many of the girls suggested that their feuds 
involved aspects of bullying. Despite reference to frequent verbal disagreements with other 
children, not one participant alluded to comments regarding the physical characteristics of 
precocious puberty during arguments.  
In addition to conflict with others, the data highlighted dysfunction within participants’ 
existing friendship groups. Some individuals generated relatively abstract ideas regarding 
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the role of friends, whilst others seemed to understand the concept of friendships, despite 
actively separating themselves from meaningful connections with others.  
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The data revealed a number of social consequences that appeared to result from hormonal 
outbursts. When asked about managing their emotions, almost all of the children 
referenced activities which they would complete in isolation. The girls implied that social 
withdrawal was used frequently as a coping mechanism. Thus, despite being unable to 
identify explicit repercussions of PA/CPP, it would appear that factors embedded within the 
girls’ conditions impacted negatively upon their social world.  
Finally, anxieties regarding social isolation were at large throughout all six interviews. Many 
children discussed experiences of seclusion within their school environment; abandonment 
was a key concern for a number of participants. Upon consideration of this concern, in 
addition to the four previously discussed themes, an issue regarding social dysfunction 
becomes apparent throughout the sample.  
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Although IPA identified two largely contrasting sets of superordinate themes, it is important 
to acknowledge the underlying relationships between explicit and implicit factors. 
Throughout this analysis, I have attempted to arrange the data into a coherent, yet accurate 
representation of lived experiences. However, only when considering the dataset as a 
whole, which is comprised of a number of complex connections, are we able to gain the 
most comprehensive account of the participants’ life-world.  
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To summarise, on one hand, a large amount of the data implied that a diagnosis of PA or 
CPP was not a primary concern for these young girls. This image was captured from 
participants’ passivity toward the healthcare experience that was framed as being an 
inconvenience that they simply “get on with”. 
However, all six children described insecurities within their social interactions, which raised 
questions regarding their ability to function socially whilst managing the physical and 
emotional components of their conditions. 
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This analysis provides an invaluable qualitative insight into the experiences of children with 
PA or CPP. It is particularly useful considering the ethical restrictions associated with the 
current sample, and provides essential comparative data that will offer a much more 
comprehensive insight when combined with the mothers’ interview data.   
In spite of these advantages, a number of limitations must be acknowledged. A female-
centric sample is restrictive to the extent that results are not generalisable to boys 
experiencing precocious puberty. Furthermore, the inclusion of children with both PA and 
CPP is flawed. As PA is limited to Adrenarche alone, girls with this condition are likely to 
have alternative experiences altogether. An example of this is the absence of menstrual 
bleeding. In addition to sampling issues, there were a number of limitations surrounding the 
interview procedure. Due to ethical constraints, each interview was highly structured and 
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contained extensive input from the researcher. IPA encourages the exploration of 
experience through participants’ own words, where the interviewer is active insofar as 
guiding the discussion. However, the current project demanded a much more dynamic role 
for the researcher. As a result, there were numerous occasions where participants’ 
responses may have been unintentionally guided by asking closed questions. Also, the 
presence of parents may have further influenced the data, as some mothers interrupted 
interviews despite being advised against doing so. 
The use of indirect questioning and play-based props during interviews may be considered a 
flaw of the current procedure, which could have impacted upon the validity of the analysis. 
However, despite the absence of direct questioning, all six of the participants initiated 
conversation regarding their diagnoses, and appeared happy to actively discuss their 
experiences of having PA/CPP. Furthermore, the dataset would suggest that adequate 
information was collected regarding the girls’ experiences of being diagnosed with PA/CPP 
without them needing to be directly questioned on their conditions. Thus, in this instance, 
the props used during interviews served as age-appropriate cues to facilitate conversation 
whilst simultaneously allowing the researcher to quickly build rapport with participants. 
Future research should aim to rectify some of the limitations mentioned. For example, 
researchers should strive to recruit mixed-sex samples, where PA and CPP should be 
explored as separate conditions.  
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After having conducted IPA during Undergraduate study, I believe I possessed a sound 
knowledge of the analytical process as a whole prior to the commencement of this 
placement. Thus, having the chance to conduct IPA again has provided me with the 
opportunity to considerably enhance my basic skillset. In addition to this, I held no previous 
knowledge of precocious sexual development and so conducting this analysis has provided 
me with the opportunity to explore a novel clinical population.  
Aside from factors related to IPA, this placement has allowed me to acknowledge a number 
of complications within clinical research. For example, throughout my analysis I was able to 
identify with the difficulties associated with analysing transcripts from interviews conducted 
by a separate researcher. As a result of this, I held no initial impressions of the dataset and I 
was unable to judge the verbal components (such as tone, hesitation, confidence) that are 
53 
 
essential throughout social interaction. In addition to this, I am now much more aware of 
the multifaceted difficulties associated with conducting research with children, especially in 
terms of ethical restrictions.  
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Upon reflection, there are a number of factors that I would have changed during the 
placement. In order to fully comprehend each interaction, I believe it would have been 
beneficial for me to have obtained audio recordings from the original interviews. Further to 
this, I would have allowed for additional time during the early stages of IPA, which would 
have provided me with an opportunity to conduct more comprehensive line-by-line coding. 
Finally, I feel it would have been beneficial for a discussion to have taken place between 
myself and the original researcher in order to share my findings. I will endeavour to arrange 
this before the analysis is written up for publication. 
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CHAPTER THREE: 
VALIDATION OF THE NEUROPSYCHOLOGICAL ASSESSMENT BATTERY SCREENING  
 
TOOL (S-NAB) IN PARTICIPANTS WITH TRAUMATIC BRAIN INJURY IN THE UK 
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Abstract 
Aim: Sustaining a Traumatic Brain Injury (TBI) can have a profound impact upon an 
individual’s cognitive functioning (Iverson, Holdnack & Lange, 2013). The ability to 
accurately recognise cognitive impairment following a TBI is imperative to rehabilitation 
planning and has been shown to predict recovery outcomes (Lau, Collins & Lorrell, 2012). 
Neuropsychological assessments are often conducted in conjunction with traditional clinical 
indicators in order to identify impairment. However, a full neuropsychological evaluation is 
resource intensive and can be frustrating for patients experiencing fatigue and low 
tolerance following a TBI. Thus, a brief screening tool to assess for cognitive strengths and 
weaknesses would prove clinically useful in the immediate post-injury stage (Allen et al., 
2013). At present, no cognitive screening tools have been validated for use within the TBI 
population. The Neuropsychological Assessment Battery Screening Tool (S-NAB) has been 
put forward as a candidate measure for brief cognitive assessment. However, only one 
study has investigated the construct validity of the S-NAB in a TBI population to date 
(Zgaljardic & Temple, 2010). The current study aims to provide additional preliminary data 
on the construct validity of the S-NAB in persons with TBI.  
Method: 22 individuals with a mild-complicated to severe TBI completed the S-NAB and a 
battery of well-established neuropsychological assessments (WAIS-IV, WMS-IV and D-KEFS) 
as part of their routine post-injury clinical care.  
Results: The S-NAB Total Index score evidenced strong and significant correlations with all 
but one domain of the WAIS-IV and WMS-IV. Significant correlations were also reported 
between the S-NAB Total Index score and many aspects of the D-KEFS. In addition to this, 
almost all of the S-NAB cognitive module index scores (Attention, Language, Spatial and 
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Executive Functioning) evidenced significant correlations with domains of the 
neuropsychological battery that measure similar cognitive functioning. Further research is 
required to investigate the S-NAB Memory module.  
Discussion: This research study provides preliminary data which supports S-NAB construct 
validity in persons with a TBI. Due to the limited sample size, the current results should only 
be used to guide further study to establish construct validity in the S-NAB.  
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Introduction 
TBI occurs as a result of damage to the brain via an external force and is a leading cause of 
disability worldwide (Allen et al., 2013). Sustaining a TBI can have a significant impact upon 
an individual’s physical, cognitive, emotional and social functioning (Iverson, Holdnack & 
Lange, 2013). Cognitive repercussions of brain injury are imperative to an individual’s 
prognosis in terms of level of disability, functioning in daily living and quality of life (Hofgren, 
2009). However, the impact of a TBI on cognitive functioning is highly individualised and 
varies between cases, which makes long-term impairment extremely difficult to predict 
(Iverson, Holdnack & Lange, 2013). Level of cognitive impairment post-injury is typically 
associated with TBI severity; profound global deficit is usually observed following the most 
critical head injuries (Allen et al., 2013).  
TBI severity is classified into mild-uncomplicated, mild-complicated, moderate and severe in 
the acute post-injury stage. Traditionally, classification is provided as a result of the 
individual’s Glasgow Coma Scale (GCS; Teasdale & Jennett, 1974) score, their duration of 
unconsciousness at the time of injury, their duration of Post-Traumatic Amnesia (PTA), and 
the results from neuroimaging. An individual’s GCS score is the clinical indicator most widely 
used by professionals whilst classifying TBI severity (Allen et al., 2013). Comprised of a 15-
point scale ranging from 0-8 (severe injury), 9-12 (moderate injury), and 13-15 (mild injury), 
the GCS score reflects the depth of coma experienced (Teasdale & Jennett, 1974). When 
used in conjunction with the other clinical indicators mentioned previously, GCS scores have 
proven useful for predicting level of recovery following a TBI (Ghosh et al., 2009). However, 
there are a number of limitations to utilising these methods alone to predict the 
heterogeneous nature of cognitive impairment following TBI (Saatman et al., 2008). 
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Ultimately, some individuals demonstrate minimal long-term cognitive deficiency despite 
receiving an initial classification of severe TBI from clinical indicators (Wells, Minnes, & 
Phillips, 2009). As a result of this, Saatman and colleagues (2008) propose that a 
multidimensional classification system, which incorporates clinical indicators and 
neuropsychological assessment, would be most useful following a TBI. They suggest that the 
results of clinical indicators from the acute stage of injury should be combined with ongoing 
neuropsychological assessment during rehabilitation, in order to most accurately classify 
injury severity and thus predict functional outcome.  
Neuropsychological assessments are regularly conducted in conjunction with standard 
neurodiagnostic procedures (such as clinical indicators and neuroimaging) following a TBI 
(Hanks et al., 2008). The scores obtained through neuropsychological testing have been 
shown to accurately predict level of recovery over time (Lau, Collins & Lorrell, 2012), 
functional outcome (Hanks et al., 2008) and return to work (Cifu et al., 1997). As discussed 
in Chapter One of this thesis, brief screening measures are perhaps more pragmatic during 
the immediate post-injury stage where clinical presentation is subject to rapid change (Allen 
& Goldstein, 2013), particularly as full neuropsychological evaluation is extremely resource 
intensive (Allen et al., 2013). In order to conduct a thorough cognitive exploration in the 
post-acute setting patients are required to complete numerous lengthy neuropsychological 
assessments during a time where individuals often demonstrate low tolerance and 
heightened fatigue (Zgaljardic & Temple, 2010). Thus, screening for cognitive impairment at 
this stage of rehabilitation allows for the identification of cognitive strengths and 
weaknesses, which can be used to gauge initial concerns and guide the ongoing assessment 
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of cognitive functioning that takes place in the months post-injury (Zgaljardic & Temple, 
2010).  
The validation of neuropsychological assessment measures within individual clinical 
populations is imperative; a clinically useful screening tool must have adequate sensitivity to 
detect post-TBI impairment and specificity to distinguish those with impairment as a result 
of TBI from matched control groups that may naturally demonstrate low cognitive 
functioning (Donders & Levitt, 2012). To date, no cognitive screening tool has been 
specifically validated within the TBI population (Zgaljardic & Temple, 2010). A 
comprehensive summary of the screening tools that have been previously administered on 
persons with a TBI is provided in Chapter One of this thesis. Of the screening measures 
discussed, the Neuropsychological Assessment Battery Screening Tool (S-NAB) was 
recognised as a potentially useful measure of global cognitive functioning following TBI.  
The S-NAB is one of six modules that comprise The Neuropsychological Assessment Battery 
(NAB; Stern & White, 2003). The NAB was designed to assess the cognitive functioning of 
individuals with neurological deficit and has previously demonstrated good sensitivity when 
administered to persons with a TBI (Donders & Levitt, 2012; Zgaljardic & Temple, 2010). The 
NAB includes five cognitive domain modules (Attention, Language, Spatial, Executive 
Functioning [EF], and Memory), as well as the S-NAB; a condensed version of the full NAB 
that functions as a screening tool for brief neuropsychological evaluation (Stern & White, 
2003). The S-NAB is also comprised of five index domains, identical to the assessment items 
on the NAB. Administration of the S-NAB provides a global index score, as well as five 
modular index scores, which reflect the level of functioning within each cognitive domain 
respectively. As proposed by White and Stern (2003) in the S-NAB administration manual, 
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adhering to the screening tool recommendations should “maximise the hit rate and 
minimise the false-negative rate” during neuropsychological assessment. Thus, should an 
individual perform well on any of the five index domains of the S-NAB, it is assumed that 
their functioning within that particular cognitive domain is adequate and so further 
assessment is not required. However, if an individual’s test results on an S-NAB domain falls 
within a certain range of scores that indicate potential impairment (as defined in the S-NAB 
manual), administration of the corresponding NAB module is warranted (White & Stern, 
2003). Results from the S-NAB can be used to direct further, more comprehensive 
neuropsychological investigation.  
At present, there are only four studies that have administered the S-NAB on persons with 
TBI (Iverson, Williamson, Ropacki & Reilly, 2007; Temple et al., 2009; Zgaljardic & Temple, 
2010; Zgaljardic, Yancy, Temple, Watford & Miller, 2011). Of these studies, Iverson and 
colleagues (2007) reported preliminary data on the sensitivity of the S-NAB to impairment 
following brain injury and compared their results to the clinical sample data provided in the 
S-NAB manual. Temple and colleagues (2009) and Zgaljardic and colleagues (2011) reported 
significant association between the S-NAB and the Functional Independence Measure (FIM; 
Rankin, 1993), which supported evidence for the ecological validity of the S-NAB with 
regards to functional ability following brain injury. Finally, Zgaljardic and Temple (2010) 
correlated individuals’ scores from the S-NAB with their results from a battery of previously 
well-established neuropsychological assessments in order to determine construct validity.  
Construct validity is traditionally thought of as the degree to which a tool is able to measure 
its desired psychological construct (Cronbach & Meehl, 1955). Thus, in this instance, 
construct validity refers to how well each of the S-NAB modules measure the respective 
63 
 
cognitive domains in which they purport to examine. As stated previously, only Temple and 
Zgaljardic (2010) have explored S-NAB construct validity. Typically, in order to validate a 
neuropsychological assessment tool within a specific clinical population, researchers 
examine the relationship between components of the instrument in question with some 
form of established “gold standard” measure (Pawlowski, Segabinazi, Wagner & Bandeira, 
2013). Zgaljardic and Temple (2010) implemented this method to examine S-NAB construct 
validity by correlating individual modular index scores with well-established tests of 
Attention, Language, Spatial, EF, and Memory. Apart from the EF module, all S-NAB modular 
index scores yielded strong and significant correlations with the “gold standard” 
neuropsychological tests selected. Alternatively, a weak and non-significant association was 
reported between the S-NAB EF index score and its matched test (Controlled Oral Word 
Association Test; Benton, Hamsher & Sivan, 1994).  
Despite their promising results, Zgaljardic and Temple (2010) identified a number of 
limitations with their research study. Firstly, the exploration of additional established EF 
tests was recommended due to their selection of a singular matched test. In addition to this, 
their sample of participants was comprised of persons with Acquired Brain Injury (ABI) 
which included individuals with acute ischemic cerebrovascular accident (CVA) as well as 
persons who had sustained a TBI. Further to this, weak internal consistency was reported 
for subtest scores that comprised each of the cognitive domains. As a result of this, the 
authors suggested that the S-NAB cognitive index scores may not reliably reflect the 
performance of participants on individual subtests. As a result of these factors, Zgaljardic 
and Temple (2010) highlighted the need for additional research to examine S-NAB construct 
validity further within individual clinical populations.   
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In sum, the S-NAB boasts a number of features to support its use within an acute 
rehabilitation setting (Temple et al., 2009; Zgaljardic & Temple, 2010). In terms of 
practicability, the test is brief in administration (approximately 45-minutes) and has two 
parallel forms which allows for repeat testing (i.e. upon hospital admission and prior to 
discharge from clinical services). Additionally, all raw index scores (including total index 
score and individual modular index scores) are standardised and reported in the form of T-
scores to allow for comparisons with a predetermined range of cut-off scores. The NAB 
manual (White & Stern, 2003) also contains extensive normative data that allows for the 
generation of a range of scores for each individual covering all five cognitive domains, as 
opposed to a singular global index score of functioning, which is found when utilising 
alternative cognitive screening tools (e.g. the MMSE). In addition to this, the normative data 
provided controls for age (18-97 years), gender, and previous education attainment, which 
are factors known to influence cognitive performance (Zgaljardic & Temple, 2010). These 
key components, combined with the advantage of gaining a neurocognitive evaluation that 
incorporates all five main cognitive domains, distinguishes the S-NAB from alternative 
neuropsychological screening tools (See Chapter One for more detail). As summarised 
previously, initial administration of the S-NAB has produced promising results in the TBI 
population. However, research in this subject field is lacking considerably. This provides an 
ideal platform on which to build the current research question.  
The aim of the current pilot study is to produce preliminary data on the construct validity of 
the S-NAB in persons with a mild-complicated to severe TBI. The results obtained from this 
research paper are intended to be used to guide a larger research study that will investigate 
the validity of the S-NAB in TBI. Similar to the study by Zgaljardic and Temple (2010), the 
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current study aims to correlate the S-NAB Total Index score, individual Modular Index 
scores, and modular subtest scores, with a battery of well-established neuropsychological 
tests.  
Thus, the aim of the current study is to: (a) examine the association between the S-NAB 
Total Index score and the Neuropsychological (NP) battery; (b) examine the associations 
between the S-NAB Modular Index scores and the NP tests matched by cognitive domain; 
and (c) examine the associations between the S-NAB modular subtests and the NP tests 
matched by cognitive domain. Finally, the data obtained is also to be used to produce a 
power analysis calculation which will guide the proposed future study. 
Methods 
Ethics 
NHS ethical approval was granted by the South Birmingham ethics committee on 23rd July 
2014 (Appendix 3A). The University Hospitals Birmingham (UHB) Research and Development 
trust granted approval for testing to take place at the Queen Elizabeth Hospital, Birmingham 
(Appendix 3B).  
Participants 
Participants were recruited through an outpatient service provided by the Queen Elizabeth 
Hospital Neuropsychology unit. Participants were considered for selection if they:  
(a) were ≥18 or ≤69 years of age,  
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(b) received a diagnosis of mild complicated, moderate or severe TBI (as judged by a 
Glasgow Coma Score between 3 and 15, loss of consciousness for ≥30 minutes, PTA 
duration of ≥24 hours, or evidence of neuroimaging abnormalities), 
(c) sustained their head injury within the last 3 years, 
(d) were able to provide informed written consent.  
Further to this, an exclusion criterion was applied and individuals were not selected to 
participate if:  
(a)  they were not sufficiently fluent in English, as judged by the Consultant 
Neuropsychologist,  
(b) they had experienced previous head trauma,  
(c) they were still in PTA,  
(d) they demonstrated motor or sensory deficits which may have impeded practical task 
completion,  
(e) a severe and enduring mental health condition was present,  
(f) a learning disability was present,  
(g) a history of pre-existing dyslexia was present, or  
(h) an organic illness (e.g. dementia) was present.  
30 participants were originally identified for the study and provided informed written 
consent (100%). Of these individuals, the results from 8 participants were excluded prior to 
analysis (26.67%) due to confounding variables (significant failure of performance validity 
tests, consumption of illicit drugs or alcohol during testing period). Therefore, 22 
participants took part in the study (8 females, 14 males) with a mean age of 37.3 years (SD= 
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15, range= 18-66) and mean educational attainment of 12.8 years (SD= 1.9, range= 10-16). 
All inclusion and exclusion criterion was adhered to by all 22 participants.  
Measures 
The S-NAB is comprised of 14 individual tests, which are separated into five index domains: 
Attention, Language, Spatial, EF, and Memory. Total index scores for each module are 
presented as standardised (mean = 100, SD = 15), and individual subtest scores are 
presented as T-scores (mean = 50, SD = 10). Of the two parallel test versions, Form One was 
used throughout this study. Full description of administration, scoring and interpretation 
can be found in the S-NAB Administration Manual (Stern & White, 2003). See Table 1 for 
breakdown of S-NAB index subtests. 
Table 1: 
S-NAB index modules, corresponding subtests and descriptive statistics 
 
S-NAB Index Domains 
 
Subtests 
 
Mean 
 
SD 
 
Range 
 
S-NAB Total Score 
 
 98.73 19.68 51-141 
S-NAB Attention  87.05 19.55 52-123 
 Digits Forwards 
Digits Backwards 
Numbers & Letters- Part A 
Numbers & Letters- Part B 
49.09 
51.00 
11.14 
10.54 
25-67 
26-66 
36.82 12.42 19-57 
38.23 9.22 25-60 
S-NAB Language  
Auditory Comprehension 
Naming 
106.82 
50.27 
20.31 
10.24 
45-127 
19-55 
53.32 13.14 19-65 
S-NAB Memory  
Shape Learning- Immediate Recognition 
Shape Learning- Delayed Recognition 
Story Learning- Immediate Recall 
Story Learning- Delayed Recall 
103.23 
54.55 
17.00 
9.39 
66-142 
34-68 
53.68 10.73 35-79 
52.41 9.28 35-67 
46.55 13.93 19.73 
S-NAB Spatial  
Visual Discrimination 
Design Construction 
104.91 
50.91 
17.31 
11.80 
77-135 
24-62 
53.41 10.88 27-68 
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S-NAB EF  
Mazes 
Word Generation 
92.55 
42.77 
19.68 
12.30 
51-141 
19.64 
49.14 11.38 26-75 
 
The Test of Memory Malingering (TOMM; Tombaugh, 1996) and the Word Memory Test 
(WMT; Green, Allen & Astner, 1996) were administered to assess performance validity 
(participants engagement with the testing process) in order to ascertain reliability of the 
results obtained for each individual (BPS, 2009). See Chapter One for rationale for the use of 
performance validity tests. The computerised version of the WMT was used in this study. 
Full description of administration, scoring and interpretation can be found in the 
Administration Manual for both tests (Tombaugh, 1996; Green, Allen & Astner, 1996).  
The battery of well-established NP tests was comprised of selected subtests from: the 
Wechsler Adult Intelligence Scale- Fourth Edition (WAIS-IV; Wechsler, 2008), the Wechsler 
Memory Scale-Fourth Edition (WMS-IV; Wechsler, 2009) and the Delis-Kaplan Executive 
Function System (D-KEFS; Delis, Kaplan & Kramer, 2001). See Table 2, 3 and 4 for breakdown 
of WAIS-IV, WMS-IV and D-KEFS subtests and corresponding cognitive domains. Full 
description of administration, scoring and interpretation can be found in the corresponding 
Administration Manuals (Wechsler, 2008; Wechsler, 2009; Delis, Kaplan & Kramer, 2001). 
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Table 2: 
Breakdown of WAIS-IV domains, subtests, descriptive statistics (scaled scores for WAIS-IV 
subtests) and corresponding cognitive abilities  
WAIS-IV Index 
Domains 
Subtests 
 
Mean 
 
SD Range Proposed Cognitive 
Abilities 
FSIQ: 
Full-scale IQ 
 
 
 
 
97.67 
 
 
14.57 70-126  
 
VCI: 
Verbal 
Comprehension 
Index  
 
Vocabulary 
99.67 14.57 70-126 Verbal reasoning, 
verbal comprehension, 
general knowledge 
9.77 2.64 3-14 
Information 10.14 3.15 4-18 
PRI: 
Perceptual 
Reasoning 
Index (PRI) 
 
 101.05 16.97 71-133 Spatial perception, 
spatial reasoning, 
problem solving 
Block Design 9.71 3.08 5-15 
Matrix Reasoning 10.72 3.47 4-16 
   
WMI: 
Working 
Memory Index 
 
 
Digit Span 
101.09 13.31 77-125 Attention, 
concentration 9.86 2.44 5-14 
Arithmetic 10.30 3.18 5-15 
PSI: 
Processing 
Speed Index  
 88.41 12.30 62-108 Visual perception, 
motor speed, visual 
working memory 
Symbol Search 8.14 2.62 3-12 
Coding 7.59 2.32 2-11 
 
 
Table 3: 
Breakdown of WMS-IV subtests, descriptive statistics (WMS-IV  and corresponding cognitive 
abilities  
Subtests Mean SD Range Proposed Cognitive Abilities 
Visual Reproduction 
Immediate 
9.52 3.17 3-14 Immediate memory, visual memory 
Visual Reproduction 
Delayed 
 
10.00 2.93 4-17 Delayed memory, visual memory 
Logical Memory 
Immediate 
 
10.73 3.39 1-15 Immediate memory, auditory 
memory 
Logical Memory 
Delayed 
10.41 3.35 1-16 Delayed memory, auditory memory 
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Table 4: 
Breakdown of D-KEFS tasks, subtests, descriptive statistics (scaled scores for D-KEFS 
subtests) and corresponding cognitive abilities 
D-KEFS 
Tasks 
Subtests Mean SD Range Proposed Cognitive 
Abilities 
Trail Making 
Test 
Motor Speed 9.71 2.54 5-13 Executive functioning, 
visual attention, task 
switching 
Number Sequencing 7.86 3.48 1-13 
Letter Sequencing 8.00 4.07 1-12 
Number-Letter 
Switching 
8.73 3.45 1-13 
Verbal 
Fluency  
 
Letter Fluency 9.14 3.48 4-19 Executive functioning, 
semantic memory Category Fluency 10.27 4.01 3-17 
Colour 
Word 
Interference  
 
Colour Naming 7.23 3.37 1-13 Executive functioning, 
processing speed, 
working memory 
Word Reading  8.31 3.61 1-14 
Inhibition 8.95 4.11 1-18 
Towers  N/A 10.91 2.22 6-15 Executive functioning, 
planning, problem-
solving 
 
Procedure 
Prior to recruitment, all participants completed a clinical assessment interview with a 
Consultant Clinical Neuropsychologist at UHB where information regarding current 
presenting problem, history of injury and severity of TBI was obtained. Participants who met 
the inclusion criterion were approached by a member of the clinical team at UHB and asked 
if they would like to take part in the research project. An information sheet (Appendix 3C) 
was provided and any queries were answered by the researcher prior to individuals’ 
scheduled appointment.  Informed consent (Appendix 3D) was obtained before testing 
commencement. Testing took place at UHB over two sessions in order to reduce fatigue. 
Each testing session lasted approximately 3 hours; the full battery was administered in less 
than 5 hours for all participants. All tests were completed orally or by using a pencil and 
paper, aside from the WMT which was computer administered. The order of tests was in 
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line with routine clinical practise and so identical for each participant. All tests were 
administered as part of routine clinical practice. As a result of this, debriefing and feedback 
of assessment scores took place as part of routine procedure at UHB.  
Analysis 
In order to explore the first aim of this research study, a Pearson product-moment 
correlation was carried out using SPSS in order to examine the association between 
participants’ S-NAB Total Index score and their results from the battery of well-established 
NP tests.  
Next, to investigate the second aim a further Pearson product-moment correlation was 
conducted in SPSS between each S-NAB module index score (Attention Index, Language 
Index, Memory Index, Spatial Index, EF Index) and the participants’ results from the NP 
battery. 
Finally, to explore the final aim of the current research project, each of the S-NAB modules 
and their corresponding subtests were examined individually by cognitive domain. Thus, five 
Pearson product-moment correlations were carried out to examine the associations 
between scores obtained from each S-NAB modular subtest and scores from the NP battery.  
In addition to the correlation statistics, a power analysis was carried out to ascertain the 
sample size required to provide sufficient power to discriminate between medium and large 
effect sizes in the larger prospective study. 
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Results 
Association between S-NAB Total Index and NP battery 
Table 5 reports the correlations between the Total S-NAB Index score and the NP battery 
comprised of tests from the WAIS-IV, WMS-IV and D-KEFS. The S-NAB Total Index score 
evidenced strong and significant correlations with all WAIS-IV domains. Significant 
correlations were also reported between the S-NAB and the Immediate Memory Index, 
Delayed Memory Index and Visual Memory Index from the WMS-IV. Three significant 
correlations were observed between the S-NAB and subtests from the D-KEFS Trail Making 
Test, two significant correlations with subtests from the Colour Word Interference task, and 
the S-NAB Total Index reached significance with the Towers test. However, there were no 
significant correlations reported between the S-NAB Total Index score and any subtests 
from the D-KEFS Verbal Fluency task.  
Associations between S-NAB Modular Index scores and NP battery 
Table 6 reports the correlations between the S-NAB Modular Index scores and the NP 
battery comprised of tests from the WAIS-IV, WMS-IV and D-KEFS.  
The S-NAB Attention Index evidenced strong and significant correlations with all but one 
WAIS-IV domains. Significant correlations were also reported between the S-NAB Attention 
Index and domains from the D-KEFS Trail Making test and D-KEFS Colour Word Interference 
test.  
The S-NAB Language domain evidenced two significant correlations with domains of the 
WAIS-IV. Aside from this, only two further significant correlations were observed between 
the S-NAB Language Index and the D-KEFS Colour Word Interference test.  
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The S-NAB Memory Index evidenced a number of significant correlations with the NP 
battery, including three significant WAIS-IV associations and two significant WMS-IV 
correlations. Further significant correlations were between the S-NAB Memory Index and 
the D-KEFS Trail Making task, the D-KEFS Colour Word Interference task and the Towers 
task.  
The S-NAB Spatial domain also reported three significant correlations with the WAIS-IV and 
two significant correlations with the WMS-IV. Further significant correlations were observed 
between the S-NAB Spatial Index and the D-KEFS Trail Making test, and the D-KEFS Verbal 
Fluency task. Finally, the S-NAB EF Index evidenced significant correlations with three WAIS-
IV domains and one WMS-IV domain. 
The S-NAB EF Index also reported one significant correlation with the D-KEFS Trail Making 
test, the D-KEFS Verbal Fluency task and the Towers task. Further to this, there were two 
significant correlations between the S-NAB EF Index and the Colour Word Interference task 
from the D-KEFS.  
Associations between S-NAB Modular subtest scores and NP battery 
S-NAB Attention subtests 
Table 7 reports the correlations between the S-NAB Attention subtest scores and the NP 
battery. All subtests in the attention domain evidenced significant correlations with NP tests 
that are routinely used to assess for attentional functioning.  
Of the S-NAB attention subtests, particularly strong associations were observed between 
Digits Forward and WAIS-IV working memory index (WMI) (r= .584, p= ≤.001, n=22), Digits 
Backwards and the Letter Sequencing (r= .540, p= ≤.001, n=22) and Number-Letter 
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Switching ((r= .612, p= ≤.001, n=22) subtests from the D-KEFS Trail Making Task (TMT). In 
addition to this, both Part A and Part B of the Numbers and Letters task evidenced 
significant correlations with subtests from the TMT. In particular, Part B: Efficacy obtained 
significant correlations with both the WAIS-IV and the D-KEFS TMT. All of the 
aforementioned tests in the NP battery are associated with the assessment of attention.  
S-NAB Language subtests 
Table 8 reports the correlations between the S-NAB Language subtest scores and the NP 
battery. Both subtests that comprise the S-NAB Language domain evidenced significant 
correlations with NP tests that are routinely used to assess language functioning.  
Specifically, the Auditory Comprehension task reached significance with the WAIS-IV Verbal 
Comprehension Index (VCI) (r= .508, p= .0.16, n= 22). Moreover, the Naming task evidenced 
a significant correlation exclusively with the WAIS-IV VCI (r= .533, p= .011, n= 22). 
S-NAB Memory subtests 
Table 9 reports the correlations between the S-NAB Memory subtest scores and the NP 
battery. Of the two subtests in the memory domain of the S-NAB, only the Logical Memory 
task evidenced significant correlations with tasks from the NP battery that are routinely 
used to assess memory.  
 In particular, the delayed recall trial of the Logical Memory task reached significance with 
all subtests from the WMS-IV: Immediate Memory Index (r= .558, p= ≤.001, n=21), and 
Delayed Memory Index (r= .502, p= .020, n=21), Auditory Memory Index (r= .561, p= ≤.001, 
n=21), and Visual Memory Index (r= .454, p= .044, n=20). There were no significant 
relationships between the delayed recall trial of the Logical Memory task and the WMS-IV, 
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however; the task did reach significance with the Category Fluency trial of the D-KEFS Verbal 
Fluency task (r= .482, p= .023, n=22), which assesses semantic memory functioning. 
Both trials of the Shape Learning task did not evidence significant correlations with any gold 
standard memory tests. 
S-NAB Spatial subtests 
Table 10 reports the correlations between the S-NAB Spatial subtest scores and the NP 
battery. Both subtests that comprise the S-NAB spatial domain evidenced significant 
correlations with the WAIS-IV Perceptual Reasoning Index (PRI), which is routinely utilised to 
measure spatial functioning: Visual Discrimination (r= .503, p= .020, n=21) and Design 
Construction (r= .543, p= .011, n=21). 
S-NAB EF subtests 
Table 11 reports the correlations between the S-NAB EF subtest scores and the NP battery. 
Both S-NAB EF subtests reached significance with tests from the D-KEFS, which is used 
regularly as a gold standard measure of EF. 
The Word Generation task evidenced significant correlations exclusively with domains from 
the D-KEFS Verbal Fluency task: Letter Fluency: Total Correct (r= .610, p= ≤.001, n= 22), and 
Category Fluency: Total Correct (r= .473, p= .026, n= 22). Further to this, the Mazes task 
reported significant associations with two of the D-KEFS Trail Making task domains: Number 
Sequencing (r= .447, p= .037, n= 22), and Number-Letter Switching (r= .467, p= .028, n= 22), 
two of the D-KEFS Colour Word Interference domains: Inhibition VS. Colour Naming (r= -
.528, p= .012, n= 22), and Colour Naming (r= .518, p= .014, n= 22), and with the D-KEFS 
Towers test (r= .489, p= .021, n=22). 
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Power Calculation 
In order to calculate an a-priori power analysis, the averaged z-score for the NP battery was 
correlated with the NAB screening index and each of the sub-indices of the screen. The 
correlations between the NP battery was correlated with the NAB screening indices ranged 
from 0.36 (average NP by S-NAB Language) to 0.68 (average NP by S-NAB Total Index score). 
Therefore,  if these analyses were to be replicated in a larger study, a sample size of 
between 15 and 58 participants would be required in order to active a power of 0.80 
(Pearson’s Product Moment Correlation, alpha = 0.05, two-tailed). 
For the future prospective study, it is proposed that data will be collected from a further 38 
participants, which will provide a sample size of 60. It is suggested that analysis of 60 
individuals’ NP assessment scores will secure a dataset that is large enough to active a 
power of 0.08, whilst ensuring that clinically relevant information is written up for 
publication and made available to clinicians as soon as possible.  
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Table 5:  
Pearson’s Product Moment Correlation between S-NAB Total Index and NP battery 
NP Battery Test  S-NAB Total Index 
Score (n=22) 
  r  p value 
WAIS-IV Full-Scale IQ 0.751 ≤.001** 
 Verbal Comprehension Index 0.538 ≤.001** 
 Perceptual Reasoning Index 0.726 ≤.001** 
 Working Memory Index 0.608 ≤.001** 
 Processing Speed Index 0.523 0.012* 
WMS-IV Immediate Memory Index 0.594 ≤.001** 
 Delayed Memory Index 0.592 ≤.001** 
 Auditory Memory Index 0.328 0.147 
 Visual Memory Index 0.471 0.036* 
D-KEFS:  Switching vs Combined Number + Letter Sequencing 0.015 0.946 
Trail Making  Number Sequencing 0.482 0.023* 
test Letter Sequencing 0.517 0.014* 
 Switching vs Motor Speed 0.303 0.238 
 Number-Letter Switching 0.592 ≤.001** 
D-KEFS:  Letter Fluency vs. Category Fluency -0.103 0.648 
Verbal Fluency Letter Fluency: Total Correct 0.389 0.073 
 Category Fluency: Total Correct 0.415 0.055 
D-KEFS: Inhibition vs. Colour Naming -0.163 0.470 
Colour Word Condition 1: Colour Naming 0.609 ≤.001** 
Interference Condition 2: Word Reading 0.584 0.017* 
 Condition 3: Inhibition 0.311 0.159 
D-KEFS: Towers Towers 0.436 0.043* 
** Correlation is significant at the 0.01 level (2-tailed) 
* Correlation is significant at the 0.05 level (2-tailed) 
Table 6:  
Pearson’s Product Moment Correlation between S-NAB Modular Index scores and NP battery 
NP Battery Test  S-NAB Attention 
Index Score (n=22) 
S-NAB Language 
Index Score (n=22)  
S-NAB Memory 
Index Score (n=22) 
S-NAB Spatial Index 
Score (n=22) 
S-NAB EF Index 
Score (n=22) 
  r  p value r p value r p value r p value r p value 
WAIS-IV Full-Scale IQ 0.616 ≤.001** 0.500 0.210 0.470 0.031* 0.641 ≤.001** 0.526 0.014* 
 Verbal Comprehension Index 0.367 0.093 0.624 ≤.001** 0.229 0.306 0.418 0.053 0.319 0.148 
 Perceptual Reasoning Index 0.584 ≤.001** 0.416 0.610 0.521 0.015* 0.673 ≤.001** 0.510 0.018* 
 Working Memory Index 0.547 ≤.001** 0.208 0.353 0.278 0.209 0.588 ≤.001** 0.556 ≤.001** 
 Processing Speed Index 0.512 0.015* 0.234 0.294 0.459 0.032* 0.331 0.133 0.343 0.119 
WMS-IV Immediate Memory Index 0.283 0.214 0.398 0.074 0.557 ≤.001** 0.568 ≤.001** 0.471 0.031* 
 Delayed Memory Index 0.334 0.139 0.394 0.077 0.438 0.047* 0.587 ≤.001** 0.473 0.030 
 Auditory Memory Index 0.108 0.642 0.169 0.465 0.350 0.120 0.210 0.361 0.360 0.109 
 Verbal Memory Index 0.206 0.382 0.341 0.141 0.390 0.089 0.439 0.053 0.333 0.152 
D-KEFS:  Switching vs Combined Number + Letter Sequencing 0.086 0.703 -0.296 0.182 -0.003 0.991 0.417 0.053 -0.071 0.752 
Trail Making  Number Sequencing 0.422 0.050 0.229 0.305 0.464 0.030* 0.209 0.350 0.423 0.050* 
test Letter Sequencing 0.530 0.011* 0.396 0.068 0.437 0.042* 0.193 0.389 0.363 0.097 
 Switching vs Motor Speed 0.331 0.194 -0.042 0.873 0.358 0.158 0.296 0.248 0.135 0.605 
 Number-Letter Switching 0.619 ≤.001** 0.208 0.354 0.501 0.018* 0.491 0.020* 0.401 0.065 
D-KEFS:  Letter Fluency vs. Category Fluency -0.154 0.493 -0.119 0.598 -0.326 0.139 0.284 0.200 -0.013 0.955 
Verbal Letter Fluency: Total Correct 0.215 0.336 0.216 0.335 0.143 0.526 0.507 0.016* 0.438 0.042* 
Fluency Category Fluency: Total Correct 0.303 0.170 0.277 0.212 0.370 0.090 0.225 0.314 0.389 0.073 
D-KEFS: Inhibition vs. Colour Naming -0.343 0.119 0.204 0.363 -0.316 0.152 0.245 0.272 -0.390 0.073 
Colour Word Condition 1: Colour Naming 0.626 ≤.001** 0.330 0.133 0.491 0.020* 0.143 0.527 0.613 ≤.001** 
Interference Condition 2: Word Reading 0.577 0.019* 0.531 0.035* 0.329 0.214 0.121 0.656 0.594 0.015* 
 Condition 3: Inhibition 0.167 0.457 0.433 0.044* 0.091 0.688 0.334 0.129 0.091 0.686 
D-KEFS: Towers Towers 0.315 0.154 -0.058 0.796 0.458 0.032* 0.392 0.071 0.501 0.018* 
** Correlation is significant at the 0.01 level (2-tailed) 
* Correlation is significant at the 0.05 level (2-tailed)
Table 7:  
Pearson’s Product Moment Correlation between S-NAB Attention Index and subtests and NP battery 
NP battery 
test 
 S-NAB 
Attention 
Index Score 
(n=22) 
Digits 
Forwards 
(n=22) 
Digits 
Backwards 
(n=22) 
Numbers 
& Letters 
(A) Speed 
(n=22) 
Numbers 
& Letters 
(A) Errors 
(n=22) 
Numbers 
& Letters 
(A) 
Efficiency 
(n=22) 
Numbers 
& Letters 
(B) 
Efficiency 
(n=22) 
WAIS-IV FSIQ 0.616** 0.437* 0.573** 0.625** 0.351 0.622** 0.482* 
 VCI 0.367 0.282 0.279 0.486* -0.062 0.472* 0.172 
 PRI 0.584** 0.355 0.620** 0.593** 0.451* 0.595** 0.432 
 WMI 0.547** 0.584** 0.412 0.388 0.356 0.383 0.514* 
 PSI 0.512* 0.212 0.549** 0.510* 0.531* 0.522* 0.530* 
WMS-IV IMI 0.283 0.132 0.416 0.374 0.108 0.373 0.126 
 DMI 0.334 0.165 0.399 0.423 0.024 0.420 0.209 
 AMI 0.108 -0.023 0.242 0.231 -0.136 0.230 0.138 
 VMI 0.206 0.069 0.381 0.362 0.008 0.357 0.108 
D-KEFS: 
Trail Making 
test 
Switching vs 
Combined 
Number + Letter 
Sequencing 
0.086 0.289 0.176 -0.077 0.240 -0.093 -0.036 
 Number 
Sequencing 
0.422 0.146 0.287 0.537** 0.260 0.541** 0.422 
 Letter Sequencing 0.530* 0.138 0.540** 0.566** 0.476* 0.581** 0.529* 
 Switching vs 
Motor Speed 
0.331 0.025 0.321 0.362 0.407 0.381 0.348 
 Number-Letter 
Switching 
0.619** 0.334 0.612** 0.614** 0.597** 0.615** 0.551** 
D-KEFS: 
Verbal  
Letter Fluency vs. 
Category Fluency 
-0.154 0.167 -0.333 -0.133 -0.152 -0.164 -0.209 
Fluency Letter Fluency: 
Total Correct 
0.215 0.543** 0.153 -0.011 -0.133 -0.007 0.073 
 Category Fluency: 
Total Correct 
0.303 0.345 0.384 0.091 -0.001 0.118 0.221 
D-KEFS: 
Colour  
Inhibition vs. 
Colour Naming 
-0.343 -0.194 -0.209 -0.387 -0.069 -0.383 -0.418 
Word 
Interference 
Condition 1: 
Colour Naming 
0.626** 0.518* 0.515* 0.570** 0.160 0.573** 0.577** 
 Condition 2: 
Word Reading 
0.577* 0.231 0.429 0.681** 0.229 0.697** 0.535* 
 Condition 3: 
Inhibition 
0.167 0.196 0.225 0.108 0.057 0.116 0.056 
D-KEFS: 
Towers 
Towers 0.315 0.418 0.325 0.118 -0.101 0.115 0.189 
Note. All values in table are Pearson’s r 
 ** Correlation is significant at the 0.01 level (2-tailed)  
* Correlation is significant at the 0.05 level (2-tailed) 
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Table 8:  
Pearson’s Product Moment Correlation between S-NAB Language Index and subtests and NP battery 
NP battery 
test 
 S-NAB 
Language 
Index Score 
(n=22) 
Auditory 
Comprehension 
(n=22) 
Naming 
(n=22) 
WAIS-IV FSIQ 0.500* 0.610** 0.319 
 VCI 0.624** 0.508* 0.533* 
 PRI 0.416 0.592** 0.218 
 WMI 0.208 0.364 0.159 
 PSI 0.234 0.502* -0.015 
WMS-IV IMI 0.398 0.523* 0.311 
 DMI 0.394 0.478* 0.297 
 AMI 0.169 0.216 0.109 
 VMI 0.341 0.387 0.280 
D-KEFS: Trail 
Making test 
Switching vs Combined 
Number + Letter Sequencing 
-0.296 -0.110 -0.184 
 Number Sequencing 0.229 0.513* -0.054 
 Letter Sequencing 0.396 0.583** 0.148 
 Switching vs Motor Speed -0.042 0.174 -0.141 
 Number-Letter Switching 0.208 0.599** -0.055 
D-KEFS: 
Verbal  
Letter Fluency vs. Category 
Fluency 
-0.119 -0.094 -0.153 
Fluency Letter Fluency: Total Correct 0.216 0.110 0.326 
 Category Fluency: Total 
Correct 
0.277 0.166 0.398 
D-KEFS:  Inhibition vs. Colour Naming 0.204 0.107 0.288 
Colour Word Condition 1: Colour Naming 0.330 0.349 0.206 
Interference Condition 2: Word Reading 0.531* 0.607* 0.303 
 Condition 3: Inhibition 0.433* 0.385 0.376 
D-KEFS: 
Towers 
Towers -0.058 -0.191 0.122 
Note. All values in table are Pearson’s r  
** Correlation is significant at the 0.01 level (2-tailed) 
* Correlation is significant at the 0.05 level (2-tailed) 
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Table 9:  
Pearson’s Product Moment Correlation between S-NAB Memory Index and subtests and NP battery 
NP test 
battery 
 S-NAB 
Memory 
Index 
Score 
(n=22) 
Shape 
Learning- 
Immediate 
Recognition 
(n=22) 
Shape 
Learning- 
Delayed 
Recognition 
(n=22) 
Story 
Learning- 
Immediate 
Recall 
(n=22) 
Story 
Learning- 
Delayed 
Recall 
(n=22) 
WAIS-IV FSIQ 0.470* 0.414 0.423 0.144 0.437* 
 VCI 0.229 0.173 0.211 0.078 0.249 
 PRI 0.521* 0.493* 0.434* 0.098 0.458* 
 WMI 0.278 0.215 0.475* 0.080 0.246 
 PSI 0.459* 0.448* 0.242 0.224 0.453* 
WMS-IV IMI 0.557** 0.406 0.334 0.229 0.558** 
 DMI 0.438* 0.303 0.250 0.120 0.502* 
 AMI 0.350 0.026 0.027 0.316 0.561** 
 VMI 0.390 0.240 0.165 0.188 0.454* 
D-KEFS: 
Trail Making 
test  
Switching vs Combined 
Number + Letter 
Sequencing 
-0.003 0.193 0.215 -0.088 -0.169 
 Number Sequencing 0.464* 0.391 0.348 0.108 0.454* 
 Letter Sequencing 0.437* 0.376 0.328 0.177 0.445* 
 Switching vs Motor 
Speed 
0.358 0.083 0.298 0.010 0.527* 
 Number-Letter 
Switching 
0.501* 0.566** 0.512* 0.096 0.405 
D-KEFS: 
Verbal  
Letter Fluency vs. 
Category Fluency 
-0.326 -0.011 -0.012 -0.386 -0.391 
Fluency Letter Fluency: Total 
Correct 
0.143 0.123 0.175 0.219 0.101 
 Category Fluency: 
Total Correct 
0.370 0.115 0.160 0.482* 0.383 
D-KEFS: 
Colour  
Inhibition vs. Colour 
Naming 
-0.316 -0.071 -0.101 -0.360 -0.373 
Word 
Interference 
Condition 1: Colour 
Naming 
0.491* 0.347 0.181 0.421 0.486* 
 Condition 2: Word 
Reading 
0.329 0.187 0.258 0.113 0.393 
 Condition 3: Inhibition 0.091 0.218 0.102 -0.061 0.018 
D-KEFS: 
Towers 
Towers 0.458* 0.137 0.324 0.316 0.403 
Note. All values in table are Pearson’s r  
** Correlation is significant at the 0.01 level (2-tailed) 
* Correlation is significant at the 0.05 level (2-tailed) 
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Table 10:  
Pearson’s Product Moment Correlation between S-NAB Spatial Index and subtests and NP battery 
NP test battery  S-NAB Spatial 
Index Score 
(n=22) 
Visual 
Discrimination 
(n=22) 
Design 
Construction 
(n=22) 
WAIS-IV FSIQ 0.641** 0.512* 0.494* 
 VCI 0.418 0.342 0.285 
 PRI 0.673** 0.503* 0.543* 
 WMI 0.588* 0.583** 0.364 
 PSI 0.331 0.183 0.347 
WMS-IV IMI 0.568** 0.295 0.621** 
 DMI 0.587** 0.316 0.631** 
 AMI 0.210 0.019 0.349 
 VMI 0.439 0.263 0.462* 
D-KEFS: Trail Making 
test 
Switching vs Combined 
Number + Letter 
Sequencing 
0.417 0.561** 0.065 
 Number Sequencing 0.209 0.088 0.257 
 Letter Sequencing 0.193 0.058 0.289 
 Switching vs Motor 
Speed 
0.296 0.026 0.573* 
 Number-Letter 
Switching 
0.491* 0.446* 0.342 
D-KEFS: Verbal 
Fluency 
Letter Fluency vs. 
Category Fluency 
0.284 0.321 0.080 
 Letter Fluency: Total 
Correct 
0.507* 0.426* 0.363 
 Category Fluency: Total 
Correct 
0.225 0.127 0.255 
D-KEFS: Colour Word 
Interference 
Inhibition vs. Colour 
Naming 
0.245 0.222 0.141 
 Condition 1: Colour 
Naming 
0.143 0.043 0.213 
 Condition 2: Word 
Reading 
0.121 0.159 0.061 
 Condition 3: Inhibition 0.334 0.262 0.274 
D:-KEFS: Towers Towers 0.392 0.185 0.445* 
Note. All values in table are Pearson’s r  
** Correlation is significant at the 0.01 level (2-tailed) 
* Correlation is significant at the 0.05 level (2-tailed) 
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Table 11:  
Pearson’s Product Moment Correlation between S-NAB EF Index and subtests and NP battery 
NP test battery  S-NAB 
Executive 
Functioning 
Index Score 
(n=22) 
Mazes 
(n=22) 
Word 
Generation 
(n=22) 
WAIS-IV FSIQ 0.526* 0.372 0.424 
 VCI 0.319 0.113 0.378 
 PRI 0.510* 0.413 0.359 
 WMI 0.556** 0.429* 0.393 
 PSI 0.343 0.300 0.216 
WMS-IV IMI 0.471* 0.347 0.397 
 DMI 0.473* 0.359 0.389 
 AMI 0.360 0.316 0.221 
 VMI 0.333 0.318 0.201 
D-KEFS: Trail Making test Switching vs 
Combined Number 
+ Letter Sequencing 
-0.071 -0.015 -0.082 
 Number 
Sequencing 
0.423* 0.447* 0.176 
 Letter Sequencing 0.363 0.381 0.168 
 Switching vs Motor 
Speed 
0.135 0.405 -0.185 
 Number-Letter 
Switching 
0.401 0.467* 0.139 
D-KEFS: Verbal Fluency Letter Fluency vs. 
Category Fluency 
-0.013 -0.095 0.075 
 Letter Fluency: 
Total Correct 
0.438* 0.054 0.610** 
 Category Fluency: 
Total Correct 
0.389 0.119 0.473* 
D-KEFS: Colour Word 
Interference 
Inhibition vs. Colour 
Naming 
-0.390 -0.528* -0.046 
 Condition 1: Colour 
Naming 
0.613** 0.518* 0.380 
 Condition 2: Word 
Reading 
0.594* 0.461 0.417 
 Condition 3: 
Inhibition 
0.091 -0.056 0.179 
D-KEFS: Towers Towers 0.501* 0.489* 0.240 
Note. All values in table are Pearson’s r  
** Correlation is significant at the 0.01 level (2-tailed) 
* Correlation is significant at the 0.05 level (2-tailed) 
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Discussion 
Conducting Pearson Product Moment Correlations revealed the associations between the S-
NAB and a battery of well-established NP tests. In turn, this provides detail regarding the 
construct validity of the S-NAB and its five cognitive modules.   
The results largely indicate good construct validity between aspects of the S-NAB and the 
current battery of well-established NP tests. Overall, this dataset provides preliminary support 
for the S-NAB as a clinically useful screening tool for persons with a TBI. The S-NAB Total Index 
score and each S-NAB modular Index and subtest scores are discussed in turn.  
S-NAB Total Index Score 
Overall, the S-NAB Total Index Score evidenced significant correlations with a large proportion 
of the battery of NP tests. Notably, strong, significant correlations were reported between the 
S-NAB Total Index and all WAIS-IV domains. In addition to this, strong and significant 
correlations were also observed between the S-NAB Total Index and all but one of the WMS-IV 
domains. Thus, aside from the Auditory Memory domain of the WMS-IV, all correlations 
between the S-NAB Total Index and the WAIS-IV and WMS-IV reached significance. In terms of 
EF, the S-NAB Total Index evidenced a number of significant correlations with components of 
the D-KEFS. In particular, significant correlations were observed between the S-NAB and 
domains of the Trail Making task, the Colour Word Interference task and Towers.  
In general, the associations between the S-NAB Total Index score and the NP battery are 
encouraging. The observation of a strong association between the S-NAB Index score and both 
the WAIS-IV and WMS-IV is particularly promising, as the administration of these NP tests is 
proposed to cover all domains of attention, language, memory and spatial functioning 
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(Wechsler, 2008; Wechsler, 2009). Thus, the current results provide initial support that 
administration of the S-NAB tool on persons with TBI would produce a Total Index score of 
similar accuracy to these well-established routine NP tests.  
Further to this, although not all associations between the S-NAB Total index and D-KEFS 
measures reaching significance, the current results provide preliminary support to suggest that 
some level of EF exploration is present. This is in contrast to the study of construct validity by 
Zgaljardic and Temple (2010) who reported no significant correlations between the S-NAB 
Total Index score and EF in individuals with a TBI. In addition to this, basic examination of EF 
would indicate that the S-NAB is somewhat superior to alternative available screening tools 
(e.g. RBANS) which are not able to provide coverage of all five core cognitive domains (McKay 
et al., 2007). 
S-NAB Attention Index score and subtests 
The S-NAB Attention Index score evidenced significant correlations with the battery of NP tests 
where expected. For example, strong and significant correlations were reported with all 
domains of the WAIS-IV aside from the Verbal Comprehension Index. As seen in the results, 
these significant results were largely uniform across all S-NAB Attention subtests. This pattern 
of results implies consistency across the cognitive domains examined by the S-NAB Attention 
module as a whole. A select number of strong and significant correlations between the S-NAB 
Attention Index (and subtest scores) and aspects of the D-KEFS Trail Making test and Colour 
Word Interference task were recorded. As before, these results were consistent across all 
subtests in the S-NAB Attention module. 
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The associations observed between the S-NAB Attention module and the NP battery are 
extremely encouraging. All significant correlations were observed with tests from the NP 
battery that are routinely administered to explore attention (WMI from the WAIS-IV, Trail 
Making test from the D-KEFS). Further to this, the consistency observed across all attention 
subtests is promising. These results mirror those of Zgaljardic and Temple (2010) who also 
observed significant associations between the S-NAB Attention module and matched NP tests. 
In sum, the current results provide preliminary support for good construct validity in the S-NAB 
Attention module.  
S-NAB Language Index score and subtests 
The S-NAB Language Index score evidenced strong and significant correlations with the Full-
Scale IQ and Verbal Comprehension Index domains of the WAIS-IV. This was largely consistent 
across both Language subtests. Most notably, all components of the S-NAB Language module 
reported significant correlations with the Verbal Comprehension Index of the WAIS-IV, which is 
traditionally used to examine language abilities. Further significant correlations were observed 
between the Auditory Comprehension S-NAB subtest and the Immediate Memory Index and 
Delayed Memory Index domains of the WMS-IV. In addition to this, the few significant 
correlations reported between the elements of the S-NAB Language module and the D-KEFS 
measure were found in the Trail Making Task and the Colour Word Interference task, which 
both include components of language to complete.  
As before, the presence of strong and significant correlations between all elements of the S-
NAB Language module and the Verbal Comprehension Index of the WAIS-IV is extremely 
encouraging. Furthermore, any additional significant correlations were observed between the 
S-NAB Language module and tasks that require an individual to utilise language (e.g. to 
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complete the D-KEFS Colour Word Interference task). Again, these results mirror the findings of 
Zgaljardic and Temple (2010), who also reported significant associations between the S-NAB 
Language module and matched NP tests. Therefore, the current results provide preliminary 
data to support the notion of construct validity between the S-NAB Language module and the 
NP battery.  
S-NAB Memory Index score and subtests 
The S-NAB Memory Index score evidenced strong and significant correlations with the Full-
Scale IQ, Perceptual Reasoning Index and Processing Speed Index of the WAIS-IV. These 
associations were relatively consistent across Memory subtests. Perhaps most notably, the S-
NAB Memory Index score reported further strong and significant correlations with the 
Immediate Memory Index and Delayed Memory Index domains of the WMS-IV. However, 
correlations between the Auditory Memory Index and Visual Memory Index domains of the 
WMS-IV and the S-NAB Memory Index did not reach significance. Furthermore, the Memory 
Index score also evidenced significant correlations with elements of the Trail Making test, the 
Colour Word Interference task and the Towers test from the D-KEFS. However, these results 
were not consistent across Memory subtests. In fact, most of the associations between S-NAB 
Memory subtests and the NP battery were largely inconsistent. Most notably, only the Story 
Learning- Delayed Recall task evidenced significant correlations with WMS-IV domains, where 
all associations between this subtest and the WMS-IV domains were significant.  
Despite the observation of significant correlations between the S-NAB Memory Index score 
and the Immediate Memory Index and Delayed Memory Index domains of the WMS-IV, the S-
NAB Memory module did not evidence consistent significant correlations across subtests. This 
is especially notable with the WMS-IV, which is one of the most widely used tests of memory 
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functioning in routine clinical practice (Wechsler, 2009). Whilst there was some evidence of 
association between the S-NAB Memory Index and the WMS-IV domains, the current results 
are not in line with conclusions made by Zgaljardic and Temple (2010), who reported 
significant associations between the S-NAB Memory module and matched memory NP tests. 
These observed differences may be due to a number of factors. Firstly, Zgaljardic and Temple 
recruited patients that had experienced ABI (which included a number of patients with CVA), 
as well as individuals who had sustained a TBI. Moreover, their participants had a history of 
moderate-to-severe ABI, which excluded individuals with a mild-complicated diagnosis. In light 
of this, further research is required to clarify these inconsistencies. Indeed, the current study 
utilised a small sample and so should only be interpreted as preliminary data to guide further 
investigation. As many of the non-significant results were approaching significance and 
reported moderate correlations, the addition of more participant data may be of benefit. 
S-NAB Spatial Index score and subtests 
The S-NAB Spatial Index score evidenced strong and significant correlations with the Full-Scale 
IQ, Perceptual Reasoning Index and Working Memory Index domains of the WAIS-IV. Notably, 
the most strong and significant correlations was observed between the S-NAB Spatial Total 
Index and the WAIS-IV Perceptual Reasoning Index, which is often administered in order to 
examine spatial reasoning abilities. These significant correlations were largely consistent across 
both spatial subtests. Further significant correlations were reported between the S-NAB Spatial 
Index score and the Immediate Memory Index and Delayed Memory Index of the WMS-IV. This 
was also true for the Design Construction subtest. Finally, very few significant correlations 
were evidenced between all elements of the S-NAB Spatial module and the four D-KEFS tasks. 
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The few significant correlations were spread across the Trail Making test, the Verbal Fluency 
task and the Towers test.  
As with the S-NAB Attention and Language modules, the presence of consistently strong and 
significant correlations between all elements of the S-NAB Spatial module and the WAIS-IV 
Perceptual Reasoning Index is encouraging. Further to this, the few significant correlations 
found between components of the S-NAB Spatial module and the D-KEFS measures were found 
in tasks that would require an aspect of spatial reasoning (e.g. as in the D-KEFS Towers task). 
Again, these findings mirror the conclusions made by Zgaljardic and Temple (2010). Thus, the 
current results would therefore provide preliminary support for good construct validity in the 
S-NAB Spatial module.  
S-NAB EF Index score and subtests 
The S-NAB EF Index score evidenced significant correlations with the Full-Scale IQ, Perceptual 
Reasoning Index and Working Memory Index domains of the WAIS-IV. However, these 
significant correlations were limited to the Index score alone and not observed in the EF 
subtests. Further significant correlations were reported between the S-NAB EF Index score and 
the Immediate Memory Index and Delayed Memory Index domains of the WMS-IV. Most 
notably, there were significant correlations observed between all components of the S-NAB EF 
module and measures from the D-KEFS. The S-NAB EF Index score evidenced significant 
correlations with aspects of all four D-KEFS tasks. In addition to this, the S-NAB Mazes subtest 
also reported significant correlations with elements from all D-KEFS tests aside from the Verbal 
Fluency task. Conversely, the S-NAB Word Generation subtest evidenced only two significant 
correlations, which were with components of the D-KEFS Verbal Fluency task. However, 
despite the presence of significant correlations, results were not consistent across Index score 
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and EF subtests. In addition to this, there were a higher number of non-significant correlations 
reported than significant associations between the S-NAB EF module and the NP battery. 
Despite inconsistencies in the associations evidenced between the S-NAB EF module and NP 
battery, some promise is evident from the current observations. Firstly, the most significant 
correlations were reported between elements of the D-KEFS measures and the S-NAB EF 
module. In addition to this, and as discussed previously, the current results provide novel data 
which suggests that examination of EF is present when administering the S-NAB tool. The 
results from this research study dispute the conclusions made by Zgaljardic and Temple (2010) 
who reported no association between the S-NAB EF module and matched NP tests of EF. Thus, 
although construct validity cannot be confirmed by this preliminary dataset, the current results 
are encouraging and warrant further investigation in future study.  
Study Limitations 
Despite the encouraging results observed in the current research study, there are a number of 
methodological limitations that warrant further discussion. As mentioned previously 
throughout the chapter, a sample size of only 22 participants was utilised. As a consequence of 
this, the current results should only be used as preliminary data to guide further study. In sum, 
a larger sample size would ensure that statistical calculations are more reliable for accurately 
reporting construct validity. Hence, it is proposed that a further 38 participants will be 
recruited for the prospective larger study at UHB.  
A further limitation of the current study is the NP tests selected for use within the NP battery. 
Despite the routine administration of the WAIS-IV, WMS-IV and D-KEFS in clinical practice 
throughout the UK, associations with the S-NAB cannot be generalised to alternative NP tests 
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which measure cognitive functioning. Whilst it would be impossible to test for statistical 
associations between the S-NAB and all other NP tests used worldwide, this factor should not 
be overlooked.  
In addition to this, the use of multiple correlations warrants consideration of the risk of 
obtaining Type I error. On this occasion, and due to aims of the current study regarding 
collection of preliminary data alone, a Bonferroni correction was not utilised. However, it is 
intended that this risk will be examined further during data analysis in the prospective study.  
Finally, and as a result of the restricted amount of participant data available, two participants 
were included in the analysis who marginally failed performance validity testing. Whilst a 
failure on such measures does not necessarily warrant the removal of an individual’s test 
results, the omission of this data would have been preferred in order to rule out the inclusion 
of potentially unreliable results.  
Conclusions 
The current research study provides preliminary data to partially support S-NAB construct 
validity and provides initial data on its clinical use within a TBI population. By completing the 
first aim of this study, a number of significant associations were observed between the S-NAB 
Total Index score and the battery of NP tests that are used within routine clinical practice to 
examine attention, language, memory, spatial and EF abilities. These results suggest an initial 
level of accuracy demonstrated by the S-NAB Total Index score. Further to this, and in line with 
the current literature available (Zgaljardic & Temple, 2010), completion of the second and third 
research aims revealed that the S-NAB Attention, Language and Spatial modules (which is 
inclusive of corresponding subtests) demonstrated good construct validity with the battery of 
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NP tests. Further to this, the S-NAB EF module reported some association with the NP battery, 
which is in opposition to previous research findings from Zgaljardic and Temple (2010). 
However, evidence of construct validity was not found in the S-NAB Memory module, which is 
in opposition to previous findings of good construct validity (Zgaljardic & Temple, 2010). 
Further to this, the current dataset provides initial data on the validity and clinical utility of the 
S-NAB on a sample of participants comprised solely of individuals who had previously sustained 
a TBI. As a result, this data should not be interpreted within the context of any additional brain 
injury population. To our knowledge, this is the first study to obtain data from an 
independently TBI sample. 
In general, the option for clinicians to administer a brief NP assessment to gauge cognitive 
functioning in the acute stage of rehabilitation is extremely resource effective during a period 
of time where patients typically experience low levels of tolerance and high fatigue following a 
TBI (Allen et al., 2013). The S-NAB tool boasts a number of advantageous characteristics which 
imply that it would serve as an ideal candidate screening tool for administration on persons 
with a TBI (Zgaljardic & Temple, 2010). Prior to routine use within clinical care, it is imperative 
to ascertain S-NAB construct validity with well-established NP tests that are used currently. 
Thus, the current research study provides preliminary data to support this notion. Due to the 
limited sample size in this study, the results obtained are intended to guide a larger project 
that is proposed to take place at UHB over the next few years. 
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Appendices: Chapter One 
1A: Reflection on Research Placement One 
Prior to the commencement of this project, the subject field was a particularly daunting aspect. 
As the majority of my previous research experience included qualitative methodology, I was 
somewhat intimidated by the Neuropsychological focus of the project. Therefore, whilst 
conducting the literature search for the cognitive screening tools detailed in part one of this 
chapter, I had to systematically read, comprehend and make notes from a substantial number 
of research papers. Without completing this exhaustive process I would not have been able to 
produce a satisfactory NHS ethics application.   
In order to complete sections of the ethics application such as “What is the scientific 
justification for the research?” I was required to conduct a mini literature review. This 
summary outlined the existing literature that described cognitive screening in TBI, the current 
clinical utility of the S-NAB and how the proposed research project could contribute towards 
establishing the validity of the S-NAB in persons with a TBI. To assist with this task, I was given 
a number of references that provided brief insight into screening for cognitive impairment in a 
TBI setting. From this, I read every published paper detailing the clinical application of the S-
NAB, which allowed me to build an initial knowledge base. In this situation I believe I worked 
efficiently during independent study, where I enhanced my personal understanding of the 
topic so that I was able to complete the majority of the ethics application without assistance. 
In the instance that I was unable to answer particular questions, I called upon the expertise of 
others and utilised my time during supervision to gain further knowledge.  
Writing each section of the ethics application in lay terminology was particularly difficult as 
much of the content was highly complex and comprised of advanced terminology. Thankfully, I 
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received great support from the research team where ultimately, almost every member 
contributed towards the application before it was prepared for submission. From this, I have 
learned to appreciate the small, individual efforts of others that can combine in order to form a 
complete article. 
One of the biggest issues I faced throughout the placement was maintaining regular contact 
with every person involved in the study. The research team was comprised of six professionals, 
as well as myself, over four different NHS sites. Almost all of those involved were consultant 
clinical psychologists who lead demanding professional lives. As a result of this, it was 
extremely difficult to obtain all of the necessary information from each member of the 
research team within particular timeframes. This made sticking to my own personal deadlines 
extremely challenging. However, despite these problems, I have now learned to be much more 
proactive with communication rather than waiting for a reply.  
In terms of completing my placement report, firstly, it was quite difficult to determine how I 
would transfer information from the NHS ethics application into a coherent, written document. 
Initially, I began by researching the cognitive screening tools that are currently used on 
patients with TBI. However, due to the literature on this topic lacking somewhat, it was 
unrealistic to base my entire report on this concept alone. My supervisor and I then decided 
that I would discuss each of the key decisions that we made as a research team throughout the 
ethics application process, which I believe captures a much more comprehensive overview of 
my time on placement. Thus, I have thoroughly enjoyed completing the first chapter of my 
thesis and I will now enter into my summer placement with confidence that I have a sound 
knowledge of the research area as a whole.  
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In sum, I feel this placement provided me with invaluable experience and I consider myself 
extremely fortunate to have had the opportunity to take on the responsibility of such an active 
role within a highly specialised research team. As the weeks progressed, I felt as though I 
developed in a professional capacity, where I now possess the self-confidence to approach 
problem-solving independently.  
On reflection, if I was given the opportunity to change any aspect of my placement then I 
would have been stricter with personal deadlines. I would have aimed to have completed the 
content of the ethics application sooner, which would have allowed for a more lenient 
deadline for each of the team members to review my draft. As a consequence of failing to 
anticipate delayed responses from each of the team, the application was not successfully 
submitted before Christmas. I hope that in my future placements, I am able to manage my 
time more successfully and make allowances in advance for unforeseen circumstances that 
may impinge on my personal schedule.  
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Appendices: Chapter Three 
3A: Copy of NRES Favourable Opinion Letter for NHS Ethical Approval 
23 July 2014   
Dear Miss Williams   
Study title: Validation of the Neuropsychological Assessment Battery (NAB) Screening Tool in 
participants with traumatic brain injury and orthopaedic controls in the UK  
REC reference: 14/WM/1006  
Protocol number: RG_13-324 
IRAS project ID: 141356   
Thank you for your letter 22nd July 2014, responding to the Committee’s request for further 
information on the above research and submitting revised documentation.   
The further information has been considered on behalf of the Committee by the Chair.    
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the 
date of this opinion letter.  Should you wish to provide a substitute contact point, require 
further information, or wish to make a request to postpone publication, please contact the REC 
Manager, Dr Ashley Totenhofer  
Confirmation of ethical opinion   
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the application form, protocol and supporting 
documentation as revised, subject to the conditions specified below.   
Conditions of the favourable opinion   
The favourable opinion is subject to the following conditions being met prior to the start of the 
study.   
97 
 
Management permission or approval must be obtained from each host organisation prior to 
the start of the study at the site concerned.   
Management permission ("R&D approval") should be sought from all NHS organisations 
involved in the study in accordance with NHS research governance arrangements.   
Guidance on applying for NHS permission for research is available in the Integrated Research 
Application System or at http://www.rdforum.nhs.uk.     
Where a NHS organisation’s role in the study is limited to identifying and referring potential 
participants to research sites ("participant identification centre"), guidance should be sought 
from the R&D office on the information it requires to give permission for this activity.   
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation.    
Sponsors are not required to notify the Committee of approvals from host organisations   
Registration of Clinical Trials   
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered 
on a publically accessible database within 6 weeks of recruitment of the first participant (for 
medical device studies, within the timeline determined by the current registration and 
publication trees).     
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g. when submitting an amendment.  We will audit the registration details as part 
of the annual progress reporting process.   
To ensure transparency in research, we strongly recommend that all research is registered but 
for non-clinical trials this is not currently mandatory.   
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If a sponsor wishes to contest the need for registration they should contact Catherine Blewett 
(catherineblewett@nhs.net), the HRA does not, however, expect exceptions to be made. 
Guidance on where to register is provided within IRAS.    
It is the responsibility of the sponsor to ensure that all the conditions are complied with before 
the start of the study or its initiation at a particular site (as applicable).    
Ethical review of research sites   
NHS sites   
The favourable opinion applies to all NHS sites taking part in the study, subject to management 
permission being obtained from the NHS/HSC R&D office prior to the start of the study (see 
"Conditions of the favourable opinion" below).   
Non-NHS sites   
Approved documents   
The final list of documents reviewed and approved by the Committee is as follows:   
Document   Version   Date   Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [Confirmation of Insurance]  UMAL  15 July 2013  Letter from sponsor [ERN_13-1321]  
University of Birmingham  20 May 2014  Letter from sponsor  University of Birmingham  20 
May 2014  Participant consent form [TBI University Hospital Birmingham]  1.1  24 June 2014   
Participant consent form [NAB-S University Hospital Birmingham Orthopaedic]   
1.1  24 June 2014   
Participant information sheet (PIS) [University Hospital Birmingham Orthopaedic Controls]   
1.1  24 June 2014   
Participant information sheet (PIS) [TBI Leamington]  1.1  24 June 2014  Participant information 
sheet (PIS) [TBI Walsall ]  1.1  24 June 2014  Participant information sheet (PIS) [TBI Moseley]  
1.1  24 June 2014  Participant information sheet (PIS) [TBI University Hospital Birmingham]  1.1  
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24 June 2014  REC Application Form [REC_Form_04062014]    03 June 2014  Research protocol 
or project proposal [NAB-S Research Protocol]  1.0  06 May 2014  Response to Request for 
Further Information      Summary CV for Chief Investigator (CI)  Theresa Powell  06 May 2014  
Summary CV for student  Elouise Williams  06 May 2014    
Statement of compliance   
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research 
Ethics Committees in the UK.   
After ethical review   
Reporting requirements   
The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including:   
 
 
 
 
 
The HRA website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures.     
Feedback   
You are invited to give your view of the service that you have received from the National 
Research Ethics Service and the application procedure.  If you wish to make your views known 
please use the feedback form available on the HRA website: http://www.hra.nhs.uk/about-the- 
hra/governance/quality-assurance/     
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We are pleased to welcome researchers and R & D staff at our NRES committee members’ 
training days – see details at http://www.hra.nhs.uk/hra-training/    
14/WM/1006                          Please quote this number on all correspondence    
With the Committee’s best wishes for the success of this project.   
Yours sincerely   
Signed on behalf of: Professor Simon Bowman Chair   
Email:   nrescommittee.westmidlands-southbirmingham@nhs.net    
Enclosures:  “After ethical review – guidance for researchers” 
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Appendix 3B: Research and Development Approval from UHB 
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Appendix 3C: UHB Participant Information Sheet 
 
 
 
 
 
PARTICIPANT INFORMATION SHEET 
Study Title: Validation of the Neuropsychological Assessment Battery Screening Tool (NAB-S) 
 
You are being invited to take part in a research study. Before you decide whether or not you wish 
to take part, it is important for you to understand why the research is being carried out and what it 
will involve. Please take time to read the following information carefully and discuss any questions 
you may have with the researcher or the collaborator at your NHS site. Please ask if there is 
anything that is not clear to you or if you would like any further information. 
The purpose of the study:  
The following research study will be completed by students from the MRes Clinical Psychology 
course at the University of Birmingham. The primary aim of our research is to collect data from a 
particular assessment that is conducted on patients who have experienced a Traumatic Brain 
Injury (TBI). The Neuropsychological Assessment Battery Screening Tool (NAB-S) is routinely used 
as a brief assessment of cognitive functioning (including domains such as memory, attention, 
language) following TBI. Ultimately, we would like to ensure that this tool is valid (that it measures 
what it should) by testing it against other assessments that are commonly used to assess cognitive 
functioning. 
Why have I been chosen? 
We are inviting people who have experienced a Traumatic Brain Injury in the last 3 years between 
the ages of 18 and 69 to participate. You have been asked as your clinical team have judged you to 
fit these criteria and feel you would be able to contribute to this research study. 
Do I have to take part? 
No- your involvement in this study is voluntary. If you decide to take part, you are still free to 
withdraw at any time without needing to give reason for this. Any decision you make to withdraw, 
or a decision not to take part at all, will have no effect on the standard of healthcare you receive 
now or in the future. 
What will happen to me if I take part? 
The researcher will meet with you at the NHS site where you receive your current medical 
treatment to carry out some assessments with you. These will consist of 8 neuropsychological tests 
that are routinely used to assess cognitive functioning. All of the tests will be carried out either 
using a pen and paper or a laptop computer.  
The tests will take around 3 hours to complete in total and you will be provided with breaks in 
between each assessment. We also encourage you to ask the researcher for breaks at your 
convenience. Alternatively, it is possible for testing to take place over 2 sessions; again this is at 
your convenience.  
Your scores from the tests will be entered into a spread sheet for analysis where you will only be 
identified by a number. This means that your data will always remain anonymous. The informed 
consent form that you will sign will be stored in a locked cupboard at the University of Birmingham 
along with all other participants’ consent forms. With your consent, your scores will also be fed 
104 
 
back to your current clinical team which could be useful to better inform your current treatment 
plan.  
Are there any risks of taking part? 
We do not expect that any part of this study will cause harm to anyone taking part. Some people 
may become tired during testing and in this case we encourage you to inform the researcher so 
that you are able to take a break. Other people may become frustrated whilst taking part in some of 
the assessments. We would like to emphasise that all of the tests you are going to complete have 
been designed to assess a wide range of functioning and there will be some aspects of these tests 
that are purposefully very difficult to complete.  
 
If at any point during or after testing you experience distress and would like to discuss it with 
someone, the contact details of the researcher and the collaborator at your NHS site are provided 
below. Equally, your clinical team will be more than willing to discuss any issues that you may 
have. 
Are there any benefits of taking part? 
Your participation in this research will provide data that will be extremely beneficial in assisting to 
further research into the validity of the NAB-S in patients with TBI in the UK, which is an important 
area of research. This could lead to more frequent use of the NAB-S as a clinical tool which would 
be much more time efficient and financially effective.  
On a personal level, should you give consent to allow for your data to be made available to your 
current clinical team, your assessment scores may provide them with additional information on 
your current cognitive functioning, which could prove useful for your treatment plan. 
What will happen when the research study stops? 
The data will be entered into a database and analysed together with data from other participants 
who took part in the study. The results will be published in journal articles, however, your identity 
or involvement in the study will never be revealed. It will be possible for you to see the results of 
the study when it is finished. 
Will I remain anonymous? 
All contributions you make towards this research study will be anonymous. Your data will be 
stored securely in a spread sheet that is only accessible by members of the research team. Your 
scores will be identified by an individual code and your name will not be used at any time other 
than on the written consent form, which will be stored in a locked cupboard at the University of 
Birmingham. 
Who has reviewed the study?  
All research in the NHS is examined by an independent group of people called a Research Ethics 
Committee. Their role is to protect your safety, rights, wellbeing and dignity. 
Who do I contact for further information? 
If you require any further information then please  
 the collaborator at your NHS site: 
 
Queen Elizabeth Hospital Birmingham:  
  
Alternatively, if you would prefer to seek advice from an individual who is independent of the 
research study please use the following contact information: 
 
pals@uhb.nhs.uk; 01213713280 (Queen Elizabeth Hospital Birmingham; B15 2WB) 
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If you are unhappy at any point during your involvement in this research study then feel free to 
contact the Chief Investigator with any concerns: 
 
 
If you would like to express your interest in participating in this study then a member of your clinical 
team will inform the research team and we will contact you from there.  
Thank you for reading this. 
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Appendix 3D: UHB Participant Informed Consent Sheet 
INFORMED CONSENT FORM 
Study Title: Validation of the Neuropsychological Assessment Battery Screening Tool (NAB-S) 
Principle Investigator: Dr Theresa Powell 
Principle Research Site: University of Birmingham 
Participant ID: 
Thank you for reading the information about our research project. If you would like to take part, 
please read and sign this form. 
PLEASE INITIAL THE BOXES IF YOU AGREE WITH EACH SECTION:          
1. I confirm that I have read the information sheet version 1.1 dated 24/06/2014 for the 
above study and I have been given a copy to keep. I have had the opportunity to consider 
the information, ask questions and I am satisfied with the answers provided. 
2. I understand that my participation in this research is completely voluntary and that I am 
free to withdraw at any time, without giving any reason, and without my medical care or 
legal rights being affected. 
3. I understand that relevant sections of my medical notes and data collected during the 
study, may be looked at by individuals from the University of Birmingham, from regulatory 
authorities or from the NHS Trust, where it is relevant to my taking part in this research.  I 
give permission for these individuals to have access to my records.  
4. I have been provided with sufficient information about the storage of my test scores and 
personal information. I understand and give permission for my data to be anonymously 
stored on the research database and this consent form to be stored in a locked cupboard at 
The University of Birmingham. 
5. I give permission for researchers to feed back my scores from this study to my current 
clinical team. 
6. I have been provided with adequate information about who to contact at my NHS site and 
how to do so if I need to. 
7. Overall, I agree to participate in this study. 
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Name of Participant : _________________________Date : ________________Signature : ________________________ 
Name of Researcher:__________________________ Date : ________________ Signature : _______________________ 
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